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ABSTRACT
The formation and disposition of sulfamethoxazole hydroxylamine (SMX-HA), a
metabolite of sulfamethoxazole (SMX), plays a critical role in the pathogenesis of
adverse drug reactions (ADRs), and can generate cellular oxidative and nitrosative
stress by forming reactive oxygen and nitrogen species (ROS/RNS). We
investigated the potential attenuation of oxidative and nitrosative stress-mediated
ADRs by baicalein, crocetin, resveratrol and schisanhenol alone and in
combination using Jurkat £6.1 cells. These compounds are presented in herbs used
as Traditional Chinese Medicine (TCM). Our results show that SMX-HA causes
cell damage mediated by ROS/RNS. Low micromolar concentrations of these four
chemicals attenuate SMX-HA-mediated LDH release, lipid hydroperoxide
formation and carbonylated protein formation, as well as the formation of protein
mixed disulfides, endpoints indicative of cytotoxicity. Treatment of cells with
equimolar mixtures of these four phytochemical antioxidants was more protective
of disulphide formation induced by SMX-HA., suggesting that defined mixtures of
pure TCM constituents may better protect against oxidative and nitrosative stress
than single chemicals in vivo.

KEYWORDS: baicalein, crocetin, disulfide proteome, LDH release, lipid
peroxidation, oxidative and nitrosative stress, protein carbonylation, protein mixed
disulfides, reactive oxygen species, reactive nitrogen species, resveratrol,
schisanhenol, sulfamethoxazole hydroxylamine
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CHAPTER 1:
1.1

INTRODUCTION

TRADITIONAL CHINESE MEDICINE
Traditional Chinese medicine, also know as TCM, is a medical system which

originated in China more than two thousands years ago (Ou, Huang et al. 2003). It
involves traditional Chinese culture, TCM theory, and the collective experiences of
a large number of TCM doctors. TCM evolved before the era of modern
biomedical research and was a unique holistic system to diagnose and cure illness.
Similar to present day medical practice, retaining a healthy status, preventing and
healing diseases were the primary objectives of TCM. Moreover, abundant
resources, unique curative methods (Zhang, Peng et al. 2010), combination
intervention, personalized therapy (Zhang, Sun et al. 2010) are all characteristics
of TCM, which have drawn more attention to TCM and popularized aspects of
TCM throughout the world. TCM is a complex medical science which includes
Chinese herbal medicine (CHM), acupuncture, Chinese food therapy, Chinese
therapeutic massage (Tui na), and other techniques like moxibustion and tai chi
chuan (Xue, Zhang et al. 2010).
Among these therapeutic methods and techniques, CHM is a well-organized
and complete medical system that involves products of natural origin. It involves
thousands of individual constituents, many of which have been documented
systematically based on their medicinal efficacy. It includes complex prescriptions
composed of preparations derived from natural plants, minerals and in some cases,
parts of animals. It has been recently reported that CHM includes 11,146 kinds of
medicinal plants, 1,581 kinds of medicinal animals, and 80 kinds of mineral drugs
(Pan, Pan et al. 2010). In China, by 2007, CHM included 3,563 extracts, 64,715
formulations, and 5,000 single compounds (Pan, Pan et al. 2010). According to a
patient’s individual condition, prescriptions are various and served either as a
boiled decoction, dried herbal extract, or pills (Flower, Lewith et al. 2010).
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In Asian countries especially in China, CHM is considered as the front line
and primary therapeutic modality in internal medicine. It was recently estimated
that CHM products account for about $31 billion annually, more than a quarter of
the total expense on all medicines in China (Flower, Lewith et al. 2010). Although
CHM is a relative newcomer in the Western world, it has attracted much attention
and is now widely accepted as complementary and alternative medicines. A report
showed that the annual research funding spent on the study of complementary and
alternative medicine (CAM), including its efficacy, in the United States’ National
Centre is more than US$120 million, which included more than 1200 projects
since 2000 (Xue, Zhang et al. 2010).
Adverse drug reactions (ADRs) refer to an undesirable secondary effect which
happens during the administration of medication (Zeng and Jiang 2010). ADRs are
affected by many factors including the nature of different drugs, individuals,
dosages, as well as the interactions of drugs. Similar to treatment with western
drugs, ADRs are also an unavoidable problem for CHM, as has been recorded in
ancient China. This issue is frequently identified but its study and subsequent
clinical reports are infrequent. Despite the fact that most of the CHM are naturally
derived and natural products are considered to exert few side effects, ADRs may
happen with improper usage and drug abuse due to the duality of medicines. The
most common ADRs of CHM are allergy and toxicity (Zeng and Jiang 2010). For
example, Ginseng is a well-known tonic that can also produce ADRs in the
nervous and digestive systems (Zeng and Jiang 2010). Side effects of CHM are
also known to occur at the cellular and gene level. For example, it was recently
reported that aristolochic acids administered with other herbal mixtures lead to
gene mutation (after metabolic activation of the aristolochic acid) and thus caused
nephrotoxic effects when they were used for slimming in European countries
(Youns, Hoheisel et al. 2010). Adverse effects following the external use of herbal
products have also received much attention. A survey in the United State showed
that the population of usage of herbal treatments had reached to 42% until 1997
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(Ernst 2000). This trend is still upwards and herbal products have gained more and
more acceptance by the public in North America. Herbal remedies are known to
improve dermatological conditions, on the other hand, some researchers have
found that some herbal products (e.g. St John’s Wort, Kava, aloe vera, eucalyptus,
camphor, henna and yohimbine) can cause dermatological side effect including
rashes and skin lesions (Ernst 2000). Compared with single drug therapy, the
ADRs of natural product-derived drugs are more difficult to analyze due to many
factors involved like individual factors, interactions with other drugs, as well as
lack of standardized processing (Zeng and Jiang 2010).
According to the WHO Collaborating Centre for International Drug
Monitoring, there has been an increasing trend of reported ADRs resulting from
treatment with TCM in the past decade (Zeng and Jiang 2010). In general, the
safety of CHM refers to the potential interaction among different herbs and
adverse reactions. Based on the completed clinical trials, mild adverse reactions
are more common than serious ADRs (Xue, Zhang et al. 2010). In this case, the
safety of Chinese herbal products has received increasing attention and has
become a major research area. Correspondingly, more and more new techniques
have emerged which are intended to help decrease the incidence of ADRs of
herbal medicines. Toxicogenomics is a multi-disciplinary and integrated field
which combines toxicology, genomics, metabolomics and proteomic approaches
(Afshari, Hamadeh et al. 2010). Nowadays, it has been widely used in evaluating
the toxicity and ADRs of drugs and TCM. Briefly, the expression of gene will be
changed after the cells are exposed to a drug or mixture used in medicine, and the
encoded gene(s) will thus influence the proteins. By detecting the production and
function of individual protein, toxicogenomics can be used for risk assessment
(Youns, Hoheisel et al. 2010). In other words, toxicogenomics is a scientific
technique that can investigate and predict the interactions and safety of TCM by
analyzing gene expression profiles and molecular mechanism for toxicity based on
cell signaling.
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1.2

OXIDATIVE STRESS AND NITROSATIVE STRESS
Oxidative/nitrosative stress is caused by the production of highly reactive

chemical species known as reactive oxygen species (ROS) or reactive nitrogen
species (RNS). Toxicity resulting from ROS/RNS occurs when the amount of
these species produced exceed the ability of cellular anti-oxidant defense
mechanisms to neutralize and eliminate the reactive intermediates or easily repair
the resulting damage (Dalle-Donne, Scaloni et al. 2005). This disturbance can lead
to damage to major cellular components including lipids, proteins, carbohydrates,
and DNA (Dalle-Donne, Scaloni et al. 2005), interfering with normal body
functions. The rate of damage is determined by how fast ROS/RNS are generated
and inactivated by anti-oxidants.
Oxidative/nitrosative stress has been implicated in many diseases including
atherosclerosis (Chang, Kou et al. 2010), diabetes and its associated complications
(Rains and Jain 2011), hepatitis (Ha, Shin et al. 2010), cancer (Bulteau and Bayot
2010) (Cobanoglu, Demir et al. 2010), respiratory disease (Gowdy, Krantz et al.
2010),

and

Alzheimer’s disease

(Barone,

Cenini

et

al.

2011).

Also,

oxidative/nitrosative stress is involved in physiological phenomena like aging and
longevity (Page, Robb et al. 2010). The chemical changes to lipids, proteins,
carbohydrates, and DNA described above contribute to each of these pathologies.
How might the concept of anti-oxidant balance, a basis of homeostasis, be
connected to TCM? Actually, a similar concept called yin-yang was recorded in
the ancient medical book, The Yellow Emperor’s Classic o f Internal Medicine,
2,500 years ago (Ou, Huang et al. 2003). In this book, the author Su Wen
illustrated that the imbalance of yin-yang was the main cause of various diseases.
Briefly, yin refers to the counteractive activities like anti-oxidant activity, while
yang represents the proactive properties like oxidation (Ou, Huang et al. 2003).
Based on this theory, CHM can be divided into yin-tonic and yang-tonic herbs.
Yin-tonic traditional Chinese herbs were regarded to possess six times more
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anti-oxidant effect than yang-tonic herbs due to their higher anti-oxidant phenolic
content (Ou, Huang et al. 2003).

1.2.1

Reactive Oxygen Species (ROS)

ROS are reactive molecules that contain the oxygen atom and are produced by
single electron reductions of molecular O2 (Bartz and Piantadosi 2010). They are
formed either through exogenous source which can involve environmental agents,
contaminants, ionizing radiation, therapeutic agents, and tobacco smoke (Klaunig,
Wang et al. 2011) or endogenous sources, including mitochondria, peroxisomes,
and inflammatory cell activation (Klaunig and Kamendulis 2004). In biological
systems,

ROS are mainly generated

in mitochondria especially during

mitochondrial respiration (Tiganis 2011). ROS refer both to free radicals and other
non-radical oxygen derivatives (Table 1) (Dalle-Donne, Rossi et al. 2003).
The generation of ROS, such as singlet oxygen C '02), hydrogen peroxide
(H20 2), superoxide anion radical (02’~) or hydroxyl radical (OH‘), is related to
respiration. O2’- is the primary metabolite of oxygen, while H2O2 is formed during
dismutation of O2’ when catalyzed by superoxide dismutase (SOD), important
cellular anti-oxidant enzyme in the body, or spontaneously. Effects of ROS on
cellular metabolism have been widely documented. Under physiological
conditions, ROS participate in the modulation of normal cellular functions which
include gene expression, signal transduction, and defense against invading
pathogens (Dalle-Donne, Scaloni et al. 2005). Taking the aging process as an
example, ROS concentrations significantly increase in the early stages of
embryonic development, and the metabolism and cell signaling initiated by ROS
play an important role in early development (Page, Robb et al. 2010). Besides,
ROS contribute to the pathogenesis and progression of several human chronic
diseases like atherosclerosis (Chang, Kou et al. 2010), diabetes (Rains and Jain
2010), hepatitis (Ha, Shin et al. 2010), as well as traumatic brain injury (Hall,
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Vaishnav et al. 2010). ROS are reactive molecules and most of them react with and
affect intracellular proteins, lipids, and DNA (as described above). However,
unrepaired damage to essential macromolecules or unabated formation of ROS
may cause cell death through apoptosis and/or necrosis (Bartz and Piantadosi
2010). For example, incubation of 50 pM of hydrogen peroxide for 18 h caused
50% of cell death in J urkat cells (Zhang, Stanley et al. 2006).
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Table 1.

Reactive Oxygen Species
Non-Radicals

Symbol

* Peroxynitrite

ONOO“

Radicals

Symbol

Hydroxyl

OH*

Superoxide

o r

Hypochlorous acid

HOC1

Peroxyl

R02-

Hydrogen
Peroxide

h 2o 2

Alkoxyl

RO-

Singlet Oxygen

'0 2

Hydroperoxyl

h o 2-

Ozone

03

* Results from the reaction of superoxide anion radical with nitric oxide (NO) and
responsible for both oxidative and nitrosative stress.
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1.2.2

Reactive Nitrogen Species (RNS)

RNS are a family of nitrogen-based molecules. These radicals are derived
from nitric oxide (/NO) and superoxide (O2’-), the former of which is generated
through the enzymatic activity of nitric oxide synthase (NOS). The form of NOS,
most important in pathology is nitric oxide synthase 2 (NOS2). Superoxide is
commonly formed from NADPH oxidase. (Wink, Miranda et al. 2001;
Dalle-Donne, Scaloni et al. 2005; Hall, Vaishnav et al. 2010).
Excessive production of RNS (Table 2) (Dalle-Donne, Scaloni et al. 2005)
cause nitrosative stress such as nitrosylation reactions that can interfere with
normal body functions. Among these radicals, nitric oxide (*NO) has received a
great deal of attention. At low concentrations (formed by NOS3 or NOS1), it is an
important endogenous mediator and possesses many beneficial physiological
actions. For example, ‘NO is a bioactive and relatively unstable free radical
involved in a number of biological process like modulation of signaling functions
by working as a second messenger (Tillmann, Gow et al. 2011). However, 'NO
may exhibit cytotoxicity at high concentration, attacking defense systems (Nathan
and Shiloh 2000) and damaging proteins, lipids, and DNA through the reaction
with superoxide or generation of powerful oxidizing and more reactive redox
derivatives like peroxynitrite (Dalle-Donne, Scaloni et al. 2005; Powers, Talbert et
al. 2011; Powers, Talbert et al. 2011). According to its mechanism of action in
biological systems, nitric oxide has two effects which include direct and indirect
effects. A direct effect refers to its direct reaction with other chemicals. However,
nitric oxide has to be activated, as in the formation of peroxynitrite, and then
continue further reaction to elicit its indirect effect (Wink, Miranda et al. 2001).
Generally, nitrosative stress is induced by three kinds of RNS which derive from
NO, including NO' radical, nitrosonium cation, and nitroxyl anion (Tillmann, Gow
et al. 2011). Another RNS that has received much attention is peroxynitrite
(ONOO‘). Peroxynitrite is generated through the reaction of nitric oxide (-NO)

with superoxide (O2 ). Peroxynitrite itself is a strong oxidizing radical which can
enter cells via anion channels (Pacher, Beckman et al. 2007). Once into the cell,
peroxynitrite oxidizes proteins, lipids, DNA, as well as low-molecular weight
anti-oxidants (O'Donnell, Eiserich et al. 1999). Other RNS including nitrogen
dioxide (-N02) and dinitrogen trioxide (N2O3) are produced through the reaction
between peroxynitrite and other molecules in the cell. Also, RNS have been
reported to be involved in the pathogenesis of some diseases, including
atherosclerosis (Chang, Kou et al. 2010), diabetes (Rains and Jain 2010), and
Alzheimer’s disease (Obulesu, Venu et al. 2011).
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Table 2.

Reactive Nitrogen Species

Nitric oxide

•NO

Dinitrogen tetroxide

n 2o 4

Nitrogen dioxide

•n o 2

Dinitrogen trioxide

n 2o 3

Nitrous acid

hno2

Peroxynitrite

ONOO-

Nitrosyl cation

NO+

Peroxynitrous acid

ONOOH

Nitrosyl anion

NO-

Alkyl peroxynitrites

ROONO

Nitronium cation

n o +2

Nitryl chloride

n o 2ci

II

1.3

REACTIVE DRUG METABOLITES
Sulfamethoxazole N-hydroxylamine (SMX-HA) is the major cytochrome

P450 (CYP) metabolite of sulfamethoxazole (SMX), an effective therapeutic drug
for the treatment of opportunistic infections (Lavergne, Kurian et al. 2006).
However, its use is largely limited in treatment of AIDS patients due to adverse
drug reactions (ADRs) to SMX, a very common problem. It has been reported that
the incidence of SMX induced ADRs is about 3%-8% of the exposed population,
while this rate is increased rise to 50% in patients infected with HIV (Castrejon,
Berry et al.

2010). These ADRs to SMX include fever, skin rash,

lymphadenopathy, hepatotoxicity and hematological disorders (Summan and Cribb
2002) and occur in HIV-infected patients approximately 7-10- days after
administration (Svensson 2003).
ADRs are a common problem caused by the use of medicine, and are major
factors contributing to hospitalization and mortality. In all of the medicines,
antibiotics, non-steroidal anti-inflammatory drugs, and antiepileptics are major
sources of the development of ADRs (Porebski, Gschwend-Zawodniak et al. 2011).
ADRs can be divided into two types: type A and type B reactions. Type A
reactions are usually caused by the pharmacologic actions of the drugs, they
possess the properties of being predictable and dose-dependent, and account for
about 80% of ADRs. For examples, drug mediated toxicity, secondary effects, and
drug interactions all belong to this type of adverse reaction (Thien 2006). Type B
reactions can not be predicted from the known primary pharmacology of drug and
are related to genetic and environmental factors. It appears in normal people
without drug overdoses and only comprises 15% of all ADRs (Posadas and Pichler
2007). In this case, type B reactions can be subdivided into immune-induced and
nonimmune-induced

reactions.

Immune-mediated

drug

allergy

includes
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IgE-mediated, T cell-mediated as well as immune-complex mediated reactions
(Fig 1) (Thien 2006).
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Figure 1. Classification of Common Adverse Drug Reactions
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Adverse drug reactions

Type A (pharmacological ) (80%)

1
Side
effects

Toxic
effects

Type B (hypersensitivity ) (10-15%)

y
Secondary
effects

IgE-mediated
Immediate reactions
(<1 hour)

Drug
interactions

Immune-mediated
{allergic) (5-10%)

T cell-mediated
Non-immediate reactions
(>1 hour)

Non-immune-mediated
(non-allergic) (5-10%)

Other

Cytotoxic or immunecomplex reactions
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A large portion (50-70%) of SMX is metabolized by acetylation to form the stable
product, N4-acetyl-SMX (Carr, Tindall et al. 1993) which is rapidly excreted in
urine. SMX is easily oxidized and about 5% of SMX undergoes oxidative
metabolism by CYP2C9 (Cribb, Spielberg et al. 1995) to form the reactive
SMX-HA metabolite.
Cytochromes P450 (CYP) are the most important group of enzymes
involved in the oxidative metabolism of drugs and other xenobiotics in humans
and experimental animals, In fact, CYP monooxygenase activity is estimated to be
responsible for about 75% of the total drug metabolism (Guengerich 2008). Some
drugs are deactivated or detoxified by CYP while others undergo bioactivation or
toxication by CYP. With drugs, particularly in combination, the activity of various
CYP isozymes may be increased by the process of induction or inhibited due to
inactivation of one or more CYP isozymes by a reactive drug metabolite. Such
changes in the metabolism of a drug can contribute to ADRs.
The metabolism of SMX has received much attention due to the widespread
use and high incidence of ADRs. After the reactive sulfamethoxazole
hydroxylamine (SMX-HA) metabolite is generated by CYP2C9, an enzyme
significant in drug metabolism in humans, it undergoes auto-oxidation to generate
the protein-reactive, oxidative metabolite sulfamethoxazole-nitroso (SMX-NO)
(Castrejon, Lavergne et al. 2010). In the absence of adequate detoxication, the
powerful immunogen, SMX-NO can react covalently with cysteine thiol residues
of cellular proteins, a preferred site, or other nucleophilic sites, to form adducts
recognized as neo-antigens by the immune system. This, in turn, can provide an
antigenic signal to T cells and elicit a T cell-mediated immune response which
presents clinically as delayed-type hypersensitivity (Fig 2) (Rieder, Uetrecht et al.
1988; Sanderson, Naisbitt et al. 2007). In addition, the mechanism of T cell
induced hypersensitivity was further studied and found to be closely related to the
cross-reaction between the T cell receptor complexes and the haptenic immunogen
(Castrejon, Berry et al. 2010). However, the initiation of an immune reaction is

Figure 2. Proposed mechanism for SMX-HA induced ROS/RNS production
and either tolerance to therapy or pathogenesis including drug
hypersensitivity, an adverse drug reaction
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decided by a prerequisite which is the neo-antigens must be presented in specific
major histocompatibility complex (MHC) molecules (Elsheikh, Lavergne et al.
2010). As shown elsewhere in this thesis, the formation and disposition of
SMX-HA and SMX-NO can generate cellular oxidative and nitrosative stress by
forming ROS and RNS. The generation of ROS happened in the auto-oxidation of
SMX-HA. In this process, molecular oxygen was reduced to superoxide, which is
catalyzed by superoxide dismutase (SOD) to form hydrogen peroxide, then
hydrogen peroxide reacts with iron via the fenton reaction to produce hydroxide
radicals, a highly cytotoxic radical (Vyas, Roychowdhury et al. 2005). Nitric oxide
is often produced simultaneously in cells and rapidly reacts with superoxide to
form peroxynitrite (Rhee, Chae et al. 2005), together with superoxide, hydrogen
peroxide, and hydroxide radicals increase in oxidative and nitrosative stress in
cells. In the study of drug-induced cytotoxicity, SMX (75 pM) was shown to
increase ROS production and lipid peroxidation in BRL3A cells (Yoshikawa,
Hosomi et al. 2009). Another study performed in NHDF cells and the result
showed concentration dependent (from 0 to 1.5 mM SMX-HA) increases in ROS
generation (Bhaiya, Roychowdhury et al. 2006). This is believed to be germane to
human disease as SMX-HA and analogous metabolites appear to be a critical
element in the pathogenesis of ADRs caused by sulfonamides (Lavergne, Kurian et
al. 2006)
Many studies have been done to investigate SMX-HA induced cytotoxicity in
T cells mainly due to the fact that lymphocytes can not generate reactive
metabolites (Reilly, MacArthur et al. 1999). Besides lymphocytes, other cell types
like peripheral blood mononuclear cells (PBMCs) were also found to be related to
SMX-HA induced drug hypersensitivity reaction. To evaluate SMX-mediated
delayed-type hypersensitivity, the in vitro measurement of cytotoxicity of
SMX-HA towards PMBCs has been proposed as a biomarker (Rieder 1997).
Timothy et al found that 3 h incubation with SMX-HA (from 0.1 Dl mM) in
PBMCs leads to the cell death in a dose-dependent manner (Reilly, MacArthur et
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al. 1999). Several in vitro tests for evaluation of hypersensitivity mediated ADRs
have been widely used. The lymphocyte transformation test (LTT) is a technique
that measures the drug specific T cell clones in the peripheral circulation from
patients who have suffered T cell mediated hypersensitivity reactions (Elzagallaai,
Knowles et al. 2009). PBMCs from patients who had an ADR to a sulphonamide
are more sensitive than cells from normal patients to the toxic effects of SMX-HA
when challenged in vitro (Uetrecht 1989). Exposure of lymphocytes to SMX-HA
causes ROS formation, leading to significant depletion of glutathione (GSH)
(Rieder, Uetrecht et al. 1988; Vyas, Roychowdhury et al. 2005), and SMX-HA
mediated ROS formation undoubtedly contributes to cytotoxicity following
treatment with SMX-HA, but whether this is a major contribution to cell death
remains unclear.
1.4

INDIVIDUAL CONSTITUENTS OF TCM SELECTED FOR

DETAILED STUDY
1.4.1

Baicalein (BE)

BE is originally derived from the roots of Scutellaria baicalensis Georgi (Fig
3-A), a plant traditionally used in herbal medicine. The main bioactive constituents
of Scutellaria are flavonoids (Woo, Cheng et al. 2005), a group of polyphenolic
compounds that are found in the human diet in many fruits and vegetables as well
as medicinal plants (Jiang, Su et al. 2010), flavonoids possess various biological
activities and act as natural anti-oxidants in plants (Piao, Cho et al. 2008). It has
been reported that some flavonoids possess anti-cancer, chemoprotective effects
(Jiang, Su et al. 2010) and anti-microbial activities (Chandrashekaran, Adda et al.
2010). BE has long been extensively used in CHM as a remedy for treatment of
respiratory tract infection, cancer (Wang, Ling et al. 2010) dysentery, jaundice,
hepatitis and hypertension (Lai, Hsiu et al. 2003).
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Recently, the anti-cancer properties of BE have received increasing attention. It
has been reported that BE leads to the inhibition of cancer cell growth. For example,
BE negatively regulates the binding of (3-catenin/Tcf complexes, a pathway
implicated in human carcinogenesis (Park and Choi 2010). Also, BE has been shown
to induce apoptosis in a variety of human cancer cells including breast,
hepatocellular, pancreatic, prostatic and urothelial carcinoma cell lines (Wang, Ling
et al. 2010). Gao et al. recently reported that BE initiates apoptosis in prostate cancer
cell lines via activation of caspase-3 and caspase-7 (Gao, Zhao et al. 2010). In
addition, BE protects against adhesion, migration and invasion of MDA-MB-231
human breast cancer cells by suppressing the activation and expression of matrix
metalloproteinases 2/9 (Wang, Ling et al. 2010).
Besides an anti-cancer effect, BE also exhibits many other biological properties
like anti-viral, anti-inflammatory, anti-thrombotic and cytoprotective activities (Piao,
Cho et al. 2008). Among its biological activities, one of the most important
beneficial effects is its anti-oxidant effect. Liu and colleagues reported that BE
inhibits the formation of ROS and decreases the level of vascular endothelial growth
factor and matrix metalloproteinase-9, which are induced by H2O2 (Liu, Wann et al.
2010). Previous studies showed that BE can scavenge ROS including superoxide,
hydrogen peroxide, and hydroxyl radicals (Hamada, Hiramatsu et al. 1993; Hanasaki,
Ogawa et al. 1994). BE also acts as a neuroprotectant through downregulating of
12/15-lipoxygenase,

p38

mitogen-activated

protein

kinase

and

cytosolic

phospholipase A2, which are modulated by oxidative stress (Cui, Zhang et al. 2010).
Also,

Chao

and co-workers

demonstrated that BE can protect against

ischemic-induced brain injury both in vitro and in vivo. This protective effect was
achieved by scavenging free radicals and protecting the PI3K/Akt and PTEN
pathways (Cui, Zhang et al. 2010). Similarly, Chang et al found that BE can protect
against ischemia/reperfusion injury and decrease cell death in cardiomyocytes
(Chang, Shao et al. 2007). In addition, Shieh et al indicated that, due to inhibition of
xanthine oxidase activity, BE can prevent free radical production and attenuate
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oxidative stress in cardiomyocytes (Shieh, Liu et al. 2000). To a great extent, the
anti-oxidant activity of BE is related to its chemical properties. In general, the
anti-oxidant capacity is related to the ability of donation of a hydrogen atom from its
phenolic groups (Chang, Shao et al. 2007). BE (Fig 3-B) possesses an o-tri-hydroxyl
structure in the A ring, a major contributor to its radical scavenging potential (Gao,
Huang et al. 1999).
Besides these properties, BE was also found to inhibit the iron-mediated lipid
peroxidation by acting as a strong iron chelator (Shieh, Liu et al. 2000). BE is
reported to have a therapeutic effect on atopic dermatitis through regulation of
molecular mediators and immune cells (Yun, Yang et al. 2010). In vivo, BE was
shown to reduce the production of inducible nitric oxide synthase (iNOS) and the
formation of excess nitric oxide (NO) by suppressing NF-kB activation (Cheng,
Lee et al. 2007). In vitro, BE exhibits an important cytoprotective effect by
scavenging the important ROS and RNS, peroxynitrite (Piao, Cho et al. 2008).
Previous work in our laboratory has shown that low concentrations of BE (5 or
10 pM) can attenuate tert-butylhydroperoxide (50 pM) induced cytotoxicity in
HEK 293 cells by attenuating oxidative stress (Xueyan Xia, 2008, unpublished).
Collectively, recent studies support the chemoprotectant role of BE, a known
anti-oxidant and immunomodulant, in protection against oxidation induced cell
damage in vitro and in vivo. This is the reason it has been included as one of the
test compounds in this thesis.
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Figure 3.

A.

Baicalein

Photo of Scutellaria baicalensis Georgi.

(Photo from Henriette Kress www.henriettesherbal.com')

B. Two and Three dimensional chemical structures of BE, IUPAC nomenclature:
5,6,7-trihydroxy-2-phenylchromen-4-one (From PubChem Public Chemical
Database, http://pubchem.ncbi.nlm.nih.gov/)
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1.4.2

Crocetin (Cro)

Cro, one of the major ingredients of saffron, is a natural carotenoid
dicarboxylic acid found in Crocus sativus (Kanakis, Tarantilis et al. 2007) (Fig
4-A). Saffron, the red dried stigmas of Crocus sativus L, is the most expensive
spice in the world. It is estimated that 75,000 flowers or 225,000 hand-picked
stigmas are needed to obtain one pound of saffron (Aytekin and Acikgoz 2008).
Saffron is used worldwide mainly due to its biological activities relevant to
biology, pharmacology, and medicine. Saffron constituents have attracted the
interest of researchers for their anti-cancer and anti-atherosclerotic activity and
curative effects against ethanol-induced memory impairments (Ordoudi, Befani et
al. 2009).
Cro, a member of the carotenoid family, has a dicarboxylic 20-carbon and
symmetrical chemical structure (Fig 4-B) which includes seven double bond and
four methyl groups. Carboxylic groups at each end of the carbon chain stabilize the
molecule (Giaccio 2004). In mice, orally administered Cro is partially conjugated
to the mono- and diglucuronides both in the intestine and in the liver. The free
form of Cro is rapidly metabolized to these glucuronide conjugates (in 8 h), one of
the reasons of its metabolic fate is different from other common C4o carotenoids
(Asai, Nakano et al. 2005).
Cro is reported to have protective and/or beneficial effects in various
conditions

including atherosclerosis,

alveolar

oxygen

transport/pulmonary

oxygenation, hemorrhage, arthritis and cancer, based on the ability of this
compound to enhance oxygen transport and diffusivity (Giaccio 2004). Cro (in
saffron) has been extensively used as traditional TCM for thousands of years and
this compound shows potential as a drug and nutraceutical.
Several, but not all of these effects may be related to the antioxidant properties
of Cro which are due to its conjugated diene structure. In human monocytes, Cro
modulates intracellular oxidative stress by suppressing the intracellular production
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of 02’° (Ordoudi, Befani et al. 2009). In mitochondria, Cro protects against
benzo[a]pyrene mediated oxidative damage by decreasing the levels of (V 3, H2O2,
and hydroxyl radical (Venkatraman, Konga et al. 2008). In addition, Cro prevents
ROS induced vascular endothelial cell apoptosis by acting as an antioxidant
(Xiang, Yang et al. 2006).
The generation of intracellular ROS is a common cause of apoptotic cell death.
It has been reported that Cro protects against H2O2 and tunicamycin induced
retinal degeneration by inhibiting the activities of caspase-3 and caspase-9
(Yamauchi, Tsuruma et al. 2011). Also, ROS are involved in the stimulation of
many signaling pathways, Cro inhibits the development of cardiac hypertrophy in
vitro and in vivo by suppressing the mitogen-activated protein kinase
(MAPK)/extracellular signal-regulated kinase-1/2 (MEK/ERK1/2) pathway, a
ROS-dependent pathway (Cai, Yi et al. 2009).
Among the beneficial biological activities of Cro, its anticarcinogenic property
has attracted more and much attention. Cro is reported to inhibit cell proliferation
and tumor progression in animal models of pancreatic cancer (Dhar, Mehta et al.
2009) and lung cancer (Magesh, DurgaBhavani et al. 2009).
Shen and co-workers reported, when evaluating the protective effects of Cro
on norepinephrine-mediated injury of rat cardiac myocytes, that in addition to
inhibiting ROS production Cro exhibited its sub-chronic effects by increasing
superoxide dismutase (SOD) activity, elevating intracellular glutathione (GSH)
content, and inhibiting Ca

influx (Shen, Qian et al. 2009) although each of these

endpoints could be positively affected by decreased ROS formation. In vitro, Cro
has been found to increase glutathione S-transferase (GST) and GSH peroxidase
(GSH-Px) activities (Giaccio 2004) but ROS is also known to inhibit the activities
of some redox regulated GST and GSH-Px isozymes so these effects could be
related to decreased intracellular ROS. In addition, Cro is reported to have a
beneficial effect for human ulcerative colitis by reducing the levels of the enzyme
inducible nitric oxide synthesis and its product, NO (Kazi and Qian 2009).
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The presence of Cro (as saffron) in effective TCM prescriptions, the fact its
antioxidant activity is not due to aromatic hydroxyl groups, and its reported
chemoprotectant effects in an number of cellular and in vivo models explain why it
was included for evaluation in this thesis.

Figure 4.

Crocetin

A. Photo of Crocus sativus L.
(Photo from: http://somethingslovelv.wordpress.com/2009/12/02/crocusA)

B. Two dimensional and three dimensional chemical structures of Cro.
IUPAC nomenclature:
2E,4E,6E,8E, 1OE, 12E, 14E)-2,6,11,15-tetramethylhexadeca2,4,6,8,10,12,14-heptaenedioic acid. (From PubChem Public Chemical Database,
http://pubchem.ncbi.nlm.nih.gov/)
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1.4.3

Resveratrol (Res)

Res has a long history as a constituent of CHM. This compound is commonly
isolated from the root of white hellebore (Das and Das 2007) (Fig 5-A). It is a
iram'-stilbene polyphenol that occurs in many other food sources like grapes,
peanuts, berries (Mercader, Palou et al. 2010) and Japanese knotweed (Jagdeo,
Adams et al. 2010). In red wine, Res is one of the most important biologically
active antioxidant components and it is present in concentrations from 0.1-15
mg/L (Cai, Fang et al. 2003).
The term “French Paradox ” was first used by Dr. Serge Renaud (Simini 2000)
who found that despite a high cholesterol and saturated fat diet, the incidence of
coronary heart disease (CITD) in France is still relatively low, which is attributed
to the regular intake of red wine (Gresele, Cerletti et al. 2010). Res has attracted
much attention recently based on the widespread consumption of red wine and the
presumed safety of natural products, including CHD.
Although initial interest focused on the cardioprotective effects of Res, more
recently it has been evaluated for many other conditions. Thus, Res has been
recently and extensively studied for its beneficial health effects, including
protection against aging, inflammation (Bereswill, Munoz et al. 2010), cancer,
neurodegeneration (Liu, Shi et al. 2011), diabetes, viral infection and Alzheimers
disease (Kapetanovic, Muzzio et al. 2010). In addition, Res has been reported to
possess antioxidant and anti-apoptotic activities, to attenuate platelet aggregation
and to modulate blood lipid metabolism (Liu, Shi et al. 2011).
Res (3,5,4'-trihydroxy-trans-stilbene) has two phenolic rings connected by a
styrene double bond (Fig 5-B). It achieves its peak plasma concentration 30 min
after oral administration in mice (Goldberg, Yan et al. 2003), however, this peak
concentration in circulating blood is inadequate to achieve effective biological
activity in vivo because of rapid metabolism to glucuronide and sulfate conjugates

(Kapetanovic, Muzzio et al. 2010). Such pharmacokinetic limitations can be
potentially overcome by repeated administration or the use of prolonged release
dosage forms in humans.
Among its large number of biological effects, its antioxidant activity has been
particularly well documented. By decreasing the production of intracellular ROS,
Res protects against oxidative stress induced death of neuron-like PC6.3-cells
(Kairisalo, Bonomo et al. 2010). In human skin fibroblasts, the generation of ROS
free radicals attenuated by Res in a dose-dependent manner (Jagdeo, Adams et al.
2010) . As an antioxidant, its protective effect includes attenuation of the oxidation
of lipid and protein.

For example,

15 MM Res

prevented ter/-butyl

hydroperoxide-induced lipid peroxidation and the damage of plasma membranes in
human sperm and in rat germinal cells (Collodel, Federico et al. 2010). Also, Res
showed significant attenuation of protein oxidation, as determined by decreased
protein carbonyl content in red blood cells and plasma (Pandey and Rizvi 2009).
Similar to ROS, RNS are also known to be involved in the pathogenesis of many
diseases. Res also protects against nitrosative stress. For example, it has been
reported that Res reduced S. enterica serovar Typhimuriiim-mduced nitric oxide
(NO) production in a time- and dose-dependent manner (Paolillo, Carratelli et al.
2011)

In some cases, the protective effect of Res is achieved through the
combination of multiple mechanisms, for example, Liu et al reported that Res
protects against the complications of spinal cord injury by upregulating SOD
activity, inhibiting neutrophil infiltration and regulating the expression of
caspase-3, an initiator of apoptosis (Liu, Shi et al. 2010). Res increases the
intracellular concentration of the critical antioxidant, GSH. More specifically,
10-100 pM Res attenuated H202-induced oxidative damage and decreased GSH
depletion (Yen, Duh et al. 2003). Xanthine oxidase is also a source of oxidative
stress. Res has been reported both to scavenge superoxide as well as prevent its
production by inhibiting xanthine oxidase activity (Jia, Zhu et al. 2008). Res was
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included for evaluation in this thesis because it is active against both ROS and
RNS stressors and it is a quantitatively important constituent of red wines and
TCM prescriptions that have been widely used for centuries.
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Figure 5.

Resveratrol

A. Photo of white hellebore
(Photo from: images.moosevscountrygarden.com/.../60/)

B. Two dimensional and three dimensional chemical structures of resveratrol.
IUPAC nomenclature: 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-l,3-diol.
(From PubChem Public Chemical Database, http://pubchem.ncbi.nlm.nih.gov/)
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1.4.4

Schisanhenol (Sal)

Sal is isolated from the ripe fruit of Schisandra rubriflora Rhed (Fig 6-A)
(Zhang, Lin et al. 1995). It was first recorded in the ancient pharmaceutical book
“Shen nong ben cao jing” as a superior drug (Lu and Chen 2009) and has been
used as a traditional CHM for 2,500 years. This CHM, which contains Sal, has
long been used as a tonic, sedative, and astringent agent (Chen, Kilgore et al. 2006)
as well as for the treatment of chronic cough and dyspnea, nocturnal emission,
spermatorrhea, enuresis, frequent urination, protracted diarrhea, spontaneous
sweating, impairment of body fluids with thirst, shortness of breath and feeble
pulse, diabetes and wasting-thirst caused by internal heat, palpitation and insomnia
(Lu and Chen 2009). Besides these effects, Sal is also reported to possess other
beneficial activities including anti-tumor, anti-hepatitis (Chen, Kilgore et al. 2006),
detoxicant, anti-HIV, and platelet-activating factor antagonistic activities (Wei,
Sun et al. 2010).
The major and characteristic bioactive constituents of the fruit of Schisandra
rubriflora are dibenzocyclooctene lignans (Chen, Kilgore et al. 2006; Lu and Chen
2009). Modern pharmacological research has found that lignans exhibit various
beneficial pharmacological effects. Eight different dibenzocyclooctene lignans
were isolated from Schisandra rubriflora (Wei, Sun et al. 2010) with Sal being the
most biologically active (Lu and Liu 1992). Sal (Fig 6-B) possesses a structure
with five methoxylated phenolic hydroxyl groups. This chemical structure
increases its lipophilicity (Chen, 2008), relative to the same molecule containing 5
phenolic hydroxyl groups, facilitating the efficient absorption of Sal into cells. Our
collaborator, Professor Daofeng Chen from Fudan University in Shanghai has
isolated, purified and characterized Sal (Chen, Kilgore et al. 2006); (Lu and Chen
2009). From in vivo pharmacokinetic studies in rats, Dr. Chen and his colleagues
found a prolonged biological half-life which is about 1.6 h of Sal because of its
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methoxylated phenolic groups. These relatively stable ether groups will be
O-demethylated by hepatic and extrahepatic microsomal cytochrome P450
isozymes to active antioxidant polyphenols, prolonging its antioxidant properties
in vivo. Vitamin E is a well-known lipophilic antioxidant whose activity depends
mainly upon its phenolic hydroxyl group (Lin, Liu et al. 1990). Sal has one
unmethylated phenolic hydroxyl group in its chemical structure so that it has
antioxidant properties even prior to P450-dependent metabolism (Lin, Liu et al.
1990). The potent antioxidant property of Sal has been attributed to its ability to
scavenge 0 2~, R‘, RO', and ROO' radicals and the inhibition of ROS generation
(Yu and Liu 2008)
Due to the inability to purchase or readily obtain pure Sal there are a paucity
of studies that have carefully evaluated its biological activities. Yu and his
colleagues reported that Sal inhibited the copper ion-ROS catalyzed oxidation of
human low-density lipoprotein to form oxidized low density lipoprotein (ox-LDL)
in a dose-dependent (from 10 MM to 100MM) manner (Yu, Liu et al. 2004). This
group also demonstrated that Sal attenuated human ox-LDL-induced apoptosis in a
bovine aorta endothelial cell model (Yu and Liu 2008). Sal is believed to be
concentrated in mitochondria of cells after exposure. Lipid peroxidation is known
to decrease membrane fluidity with the loss of ATPase activity in rat liver
mitochondrial and microsomes, however, these oxidant effects were significantly
inhibited by 1 mM Sal (Lin, Liu et al. 1992; Lu and Liu 1992). It has also been
reported that 1 mM Sal prevented Vit C/NADPH induced lipid peroxidation in rat
liver microsomes (Lu and Liu 1991), but these concentrations are very high for
potential therapeutic use.
Sal has also been reported to have an effect on the CYP monooxygenase
system. Liu et al (1985) reported that Sal can protect against CCL-mediated liver
injury via induction of hepatic microsomal monooxygenases, although this seems
to be an unlikely mechanism for chemoprotection. These authors noted an increase
in aminopyrine demethylation activity (Liu and Wei 1985), a pathway catalyzed by
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CYP isozymes and Lu et al (1990) also reported that Sal and Schizandrin, 200
mg/kg administered once daily by intragastric lavage, increased glutathione
S-transferase and total CYP in mice and rats in vivo (Lu and Liu 1990). These are
also high dose effects.
The protective effects of Sal also involve other mechanisms. For example,
Schisanhenol can inhibit ethanol mediated malondialdehyde formation, a marker
for lipid peroxidation, in vivo through increasing superoxide dismutase and
catalase activities in the cytosol of rat liver (Lu and Liu 1991). Oral administration
of Sal (200 mg/kg once daily for 3 days) in mice and rats can enhance liver
glutathione-S-transferase (GSH S-T) level (Lu and Liu 1990).
Sal was selected as one of the TCM constituents in this thesis because it is
reported to be concentrated in mitochondria, it has antioxidant activity both
independent of and dependent upon metabolic activation to phenolic hydroxyl
groups, and it has prolonged in vivo stability because of extensive methoxylation
(5 of 6) of its phenolic hydroxyl groups. In addition, few carefully controlled
experiments have been performed to evaluate the chemoprotectant properties of
Sal at doses that might be used for chemoprotection.
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Figure 6. Schisanhenol

A. Photo of Schisandra rubriflora Rhed fruit
(Photo from: www.nutralegacy.com/wp-content/uploads/2008/1)

B. Two dimensional and three dimensional chemical structures of schisanhenol.
IUPAC name: 5,6,7,8-tetrahydro-2,3,10,11,12- pentamethoxy-6,7-dimethyldibenzo(a,c)cycloocten-l-ol ((From PubChem Public Chemical Database,
http://pubchem.ncbi.nlm.nih.gov/)
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1.4.5

Mixtures of purified active TCM constituents

In the clinical application of TCM, each remedy routinely contains hundreds
of constituents and is seldom used alone. Most times, different natural products are
combined into prescriptions to achieve better therapeutic effect. The combination
of TCM preparations is based on practical experience and the basic theories of
TCM. Although each different TCM product has its own biological properties,
pharmacological activity and sphere of application, the interactions among the
herbal medicines that can occur either alone or because of their combinatorial use
has received more and more attention in the last two decades (Li, Wang et al.
2010). These herbal interactions produce positive and/or negative effects on the
therapeutic efficacy which can enhance the curative effect or increase unwanted
side effects. As with interactions between drugs used in Western medicine,
induction or inhibition of drug-metabolizing enzymes and/or drug transporters are
an important contributor to these interactions (Li, Wang et al. 2010). The
formulated combinations of herbal medicines may lead to higher toxicity or better
therapeutic effects by enhancing or reducing their plasma and tissue
concentrations.
Among these herbal interactions, synergistic effects are of particular note.
Synergism in medicine can be defined as two or more medicines working together
to generate a more powerful positive effect not obtainable by any of the medicines
singly (from Wikipedia). Many TCM medicines and constituents are known to
possess antioxidant effects and each single constituent may function through a
different mechanism, including direct antioxidant actions, increasing the level of
endogenous antioxidants,

attenuation or repair of oxidative damage (Afltab,

Likhitwitayawuid et al. 2010). For example, resveratrol and curcumin are two
well-known antioxidants. An equimolar (5 MM) combination of resveratrol and
curcumin achieved two-fold greater antioxidant activity than either compound
singly (Aftab, Likhitwitayawuid et al. 2010). Besides antioxidant effects,
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synergism also occurs with other activities. In vivo, the mixture of emodin (2.5
mg/kg) and baicalein (20 mg/kg) was injected through the jugular vein into rats,
and the pancreatic TNF-a, IL-6, and myeloperoxidase activity were measured 12 h
later. The results showed that the combination of emodin and baicalein showed
more powerful inhibition of acute pancreatitis than emodin or baicalein alone (Li,
Xia et al. 2009). In vitro, a synergistic anti-cancer effect of baicalein and silymarin
was detected in the alteration of cell cycle, especially in the Gl/S transition in
human hepatoma HepG2 cells (Chen, Huang et al. 2009). Research with several
promising antioxidants has rarely attempted to characterize the effects of both
single constituents of varying structure and function/mechanism and formulated
combinations of these compounds. We have evaluated BE, Cro, Res and Sal
individually and as mixtures, to determine if they might act synergistically to
prevent or attenuate oxidative damage through complementary antioxidant or
immunomodulant mechanisms. The premise of this work is that high nanomolar or
low micromolar doses of these compounds will be required for effective protection
against ADRs in humans, especially children.

1.5

INTEGRATED ASSAYS FOR OXIDATIVE AND NITROSATIVE

STRESS INDUCED CELL TOXICITY
In our project, Jurkat T cells were selected to investigate the reactive drug
metabolite (SMX-HA) induced cytoxicity. High level expression of T cells in blood
and skin from patients with drug hypersensitivity reactions indicated that T cells,
work as an vital

immune mechanism to regulate the development of

immune-induced ADRs (Naisbitt, Pirmohamed et al. 2007) We have evaluated the
effects of SMX-HA-mediated oxidative and nitrosative stress in the Jurkat £6.1 cell
line. These cytotoxic endpoints include lactate dehydrogenase (LDH) release, as an
index of damage to the external membrane of Jurkat £6.1 cells treated with DMSO
(vehicle control); SMX (negative control) or SMX-HA (the oxidative and nitrosative
stressor) in the presence and absence of low micromolar concentrations of BE, Cro,
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Res and Sal, alone or in combination. In addition, the amount of lipid peroxidation
and protein carbonylation (endpoint for protein oxidation) that occurred under the
same treatment conditions as outlined above were investigated to evaluate the ability
of the various phytochemicals investigated to attenuate damage to these cells. In
addition, we analyzed the contents of treated Jurkat £6.1 cells by redox-two
dimensional polyacrylamide gel electrophoresis (R2DPAGE) to determine the types
and amount of protein mixed disulphides formed as an index of the oxidation of
proteins containing reactive protein thiol residues, that is cysteine residues that were
ionized at physiological pH. This is an excellent assay for changes in the oxidation
state of proteins that contain one or more reactive cysteine thiol residue, and are
redox regulated.
1.6

DISULFIDE PROTEOME
Proteome refers to all of the proteins that are found in a particular cell type,

and includes different molecular forms of the same protein formed by such well
known

post-translational

modifications

ubiquitation, S-glutathionylation.

as

acetylation,

phosphorylation,

The disulphide proteome describes only those

proteins that contain cysteine residues with reactive protein thiols which are redox
regulated . The thiol group of reactive cysteine residues is one of the most reactive
amino acid side chains in protein and peptides (Perez, Pierce et al. 2010). The
protein-protein disulphide bond is derived from pairs of thiol groups of cysteine
residues and is the most common of the oxidized modifications of thiol group,
after S-glutathionylation. The formation of mixed protein disulfides occurs
because of the oxidation of sulphhydryl (-SH) groups and this reaction is promoted
by many oxidants including iodine, hydrogen peroxide, and copper (Dalle-Donne,
Scaloni et al. 2005). However, disulphide bonds are also produced in the
endoplasmic reticulum (ER) in eukaryotic cells with the absence of exogenous
oxidation (Cumming, Andon et al. 2004). The disulphide bond is a weak link in
many molecules and unstable in the cytosol due to the reducing environment of
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most cells (Hatahet, Nguyen et al. 2010). The property of thiol group made it
sensitiv to oxidation. This redox regulation by oxidation of reactive protein thiol
can induce structural changes in protein and lead to the modification of protein
functions. Based on this, disulphide proteomics has been widely used to identify
the proteins involved in redox regulation and signaling. For example, disulphide
bond has been reported to possess various activities in protein regulation such as
the control of protein folding, the stabilization of the native states of proteins via
protection against the attack of ROS (Liang and Fernandez 2009; Arai, Dedachi et
al. 2011).
Protein disulphide bonds are a reversible modification. Protein disulphides can
be reduced to their thiol state, or be further oxidized by strong oxidants to protein
sulphinic and sulphonic acids. Glutathione protein mixed disulphides may be
involved in cell signaling (Lindahl, Mata-Cabana et al. 2011). The reduction of the
disulfide bond at most times occurs through the thiol/disulfide exchange reaction. In
this reaction, the original disulfide bond is attacked and replaced by a new disulfide
bond which is formed between the attacking thiolate and the original protein sulfur
atom (Gilbert 1995). In vitro, dithiothreitol (DTT) is a commonly used dithiol
reducing agent which can reduce protein disulphides to their constituent thiols and
also prevent the formation of additional disulfide bonds (Liang and Fernandez 2009).
DTT was used in this project (2D-PAGE) to reduce protein disulphide bonds prior to
resolution of cellular proteins in the second dimension of R2DPAGE.
Under physiological conditions, the reduction of protein disulphide bonds
involves two systems in the cytoplasm, that includes cysteine-containing tripeptide
glutathione (GSH) or thioredoxin. Both systems reduce disulphide bonds through a
thiol-disulfide interchange reaction and a dithiol-disulfide exchange reaction,
respectively (Cumming, Andón et al. 2004). As we mentioned above, protein
cysteine are susceptible to attack by ROS and RNS (Mieyal, Gallogly et al. 2008).
Mild oxidation of protein reactive cystein cysteines thiols can generate
protein mixed disulfides which are derived from protein thiol groups, or
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low-molecular-mass disulphides resulting from reaction of an oxidized proteins
cysteine thiol with the thiol of GSH. The first step in either S-glutathionylation of
protein mixed disulphide formation is oxidation of protein reactive cysteine thiol to
protein cysteine sulphenic (PSOH) acid. The PSOH derivative can either react
non-enzymatically wither with a thiol of proteins or GSH, to form a protein-protein
disulphide or a protein-glutathione disulphide (Giustarini, Rossi et al. 2004),
respectiviely. The PSOH, in the formation of excess ROS or RNS can be further
oxidized to form irreversible, highly oxidized states such as protein sulphinic
(PSO2H) and protein sulphonic (PSO3H) acids (Fig 7). These post-translational
modifications in the dithiol/disulfide state of protein can cause alterations in the
functions of the protein (Jeong, Jung et al. 2011).
Redox two-dimensional SDS-PAGE is one of techniques that has been
widely used in recent years to identify proteins that contain either intra- or
intermolecular disulphide bonds in cells (Leichert and Jakob 2006). In our project,
this technique was used to identify disulfide-bonded proteins. Overall, disulfide
proteomics, although time consuming and not suitable for proteins that occur at low
concentrations in cells, is an excellent endpoint to evaluate intracellular changes to
proteins that occur as a result of oxidative or nitrosative stress.
1.6.1

Redox-regulated Peroxiredoxins

Peroxiredoxins (Prxs) belong to an ubiquitous family of antioxidant enzymes
that are highly expressed in many cell types (Li and Fu 2010), including Jurkat cells
(Cox, Pearson et al. 2009). Prxs are thiol-dependent peroxidases which control the
level of toxic peroxides and peroxynitrites in cells (Tripathi, Bhatt et al. 2009). The
first Prxs were found in Saccharomyces cerevisiae where these enzymes prevent the
oxidation of glutamine synthase (Kim, Kim et al. 1988). The majority of the Prxs are
located in the cytosol. Prxs are generally divided into three classes: typical 2-Cys
Prxs, atypical 2-Cys Prxs, and 1-Cys Prxs. All of them contain at least one reactive
cysteine thiol at the N-terminal region of the protein. In addition, 2-Cys Prxs contain
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another reactive cysteine at the C-terminal region of the protein (Robinson,
Hutchinson et al. 2010) and fulfill the catalytic activity through the oxidation of
redox-active cysteine to a sulphenic acid (Abbas, Breton et al. 2008), as described
above, by reacting with peroxides, the cysteine residue at its primary catalytic center
of Prxs is oxidized to a sulphenic acid. The sulfenic acid is reduced through a next
catalytic step which is the reaction with another thiols to form an intermolecular
(2-Cys Prx) or intramolecular (1-Cys Prx) bond (Tripathi, Bhatt et al. 2009). The
reaction of Prxs is a cycle which includes three steps: oxidation, derivatization, and
regeneration (Hofmann, Hecht et al. 2002).
Prxs exhibit many important physiological properties mainly due to their
relative abundance, which account for up to 1% of all soluble cellular protein (Cox,
Winterbourn et al. 2010). More and more studies have shown the critical role that
Prxs play to protect the cells of different organisms through controlling hydrogen
peroxide signaling and oxidative and nitrosative stress (Shuvaeva, Novoselov et al.
2009) . Also, Prxs have been reported to be involved in various cellular functions
such as proliferation, cell cycle, apoptosis, as well as differentiation (Abbas, Breton
et al. 2008). Most recently, Prxs was reported to be involved in the immune
modulation via binding and activation of antigen presenting cells (Hall, Nelson et al.
2010) .

In our project, we used redox two-dimensional SDS-PAGE to identify the
change in oxidation state of proteins that form either intra- or intermolecular
disulfide bonds in Jurkat E6.1 cells. The Prx enzymes are particularly good
biomarkers to evaluate the oxidative effect of the reactive drug metabolite,
SMX-HA, because some of these enzymes are present at high concentration and the
normal catalytic cycle includes a dimeric disulphide that shows up on analysis.
Excess oxidation of these Peroxiredoxins to their sulphinic or sulphonic acid
derivatives results in their apparent disappearance from the gel because they are not
reduced by DTT. The protein, Prx 1 and 2 were used as our key biomarkers in the
R2DPAGE experiments because, among the redox regulated proteins, they occurred
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at the highest concentration. This protein is also expressed at high concentrations in
other cell types, including erythrocytes (Low, Hampton et al. 2008). Prx 2 also plays
a critical role in the detoxication of ROS and RNS. An earlier proteomic study also
noted that Prx 2 (along with GAPDH) was the most sensitive protein to oxidation in
Jurkat cells following exposure to relatively low concentrations (20 pM for 10 min)
of hydrogen peroxide (Baty, Hampton et al. 2005).
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Figure 7.

Redox regulation of reactive protein cysteine thiol (PS-) residues
(adapted from Biteau, B.et al. 2003. Nature 425, 980-984)
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CHAPTER 2:

OVER-RIDING RESEARCH HYPOTHESES

AND SPECIFIC OBJECTIVES
Different cellular redox systems protect the reduced intracellular status in the
face of a highly oxidizing extracellular environment. The in vitro cytotoxicity of
SMX-HA in PBMCs has been used previously as a model for the study of
delayed-type hypersensitivity reactions associated with sulphonamide drugs (Vyas,
Roychowdhury et al. 2005). Exposure of lymphocytes to SMX-HA would be
predicted to result in the formation of ROS and RNS (Rieder, Uetrecht et al. 1988).
It has been shown that, under biological conditions, SMX-HA auto-oxidizes to its
nitroso metabolite, which would be anticipated to produce downstream oxidative
and nitrosative stress (Rieder, Krause et al. 1995).
Four pure constituents of traditional Chinese remedies, baicalein (BE),
crocetin (Cro), resveratrol (Res), and schisanhenol (Sal), have antioxidant
properties and are reported to attenuate cytotoxicity of chemicals associated with
oxidative or nitrosative stress in different cell model systems. The reason for the
selection of these four compounds is that they are structurally diverse, with the
potential that they will have complementary mechanisms of chemoprotectant
activity. These chemicals were evaluated individually, and as two equimolar
mixtures, for their ability to counteract the toxic effects of SMX-HA in Jurkat E6.1
cells to test for enhanced activities of the equimolar (vs single constituent)
mixtures. The TCM constituents were tested for their ability to acutely attenuate
SMX-HA-mediated damage to the cell membrane, as well as increased cellular
lipid peroxidation and protein oxidation, the latter assessed by the degree of
protein carbonylation and oxidative changes to the disulphide proteome.
Jurkat £6.1 cells, a human leukaemic T cell lymphocyte line, were selected for
the determination of SMX-HA cytotoxicity in this thesis as they are a cell line
derived from lymphocytes; extensive earlier work by Spielberg and his colleagues
(Rieder at al, 1988; 1989; 1995) showed that peripheral blood mononuclear cells
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(PBMCs), composed of lymphocytes, monocytes and macrophages, from patents
with an ADR to SMX are more sensitive to SMX-HA that those from controls and
that a useful model system for hypersensitivity ADRs can be based on cells of
lymphocytic origin.

Over-riding Research Hypothesis
1.

The administration of purified constituents of TCM in Jurkat £6.1 cells, in

combination, at high nMolar or very low pMolar doses will attenuate the oxidative
and nitrosative stress associated with administration of drugs such as
sulphonamides that cause ADRs.
2.

The attenuation of the oxidative and nitrosative stress mediated by drugs

causing ADRs will, in turn, attenuate the severity of the ADR, providing
chemoprevention under ideal conditions.

Specific Objectives
1.

Determine the effects of BE, Cro, Res and Sal, alone and in combination, on

Jurkat £6.1 cells in a time and concentration-dependent manner.
2.

Determine the acute, concentration-dependent cytoprotective effects of the

pre-exposure of Jurkat £6.1 cells to BE, Cro, Res and Sal, alone and in
combination, on the amount of lactate dehydrogenase (LDH) released subsequent
to treatment with SMX-HA.
3.

Determine the acute, concentration-dependent cytoprotective effects of the

pre-exposure of Jurkat £6.1 cells to BE, Cro, Res and Sal, alone and in
combination, on the amount of lipid peroxide formed subsequent to treatment with
SMX-HA.
4.

Determine the acute, concentration-dependent cytoprotective effects of the

pre-exposure of Jurkat £6.1 cells to BE, Cro, Res and Sal, alone and in
combination, on the protein carbonyls formed subsequent to treatment with
SMX-HA.
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5.

Determine the acute, concentration-dependent cytoprotective effects of the

pre-exposure of Jurkat £6.1 cells to BE, Cro, Res and Sal, alone and in
combination, on the oxidative changes to the disulphide proteome, especially at the
level of the redox-regulated peroxiredoxins, subsequent to treatment with
SMX-HA.
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CHAPTER 3:
3.1

MATERIALS AND METHODS

MATERIALS AND CHEMICALS
High quality TCM constituents commercially available (>95% purity) were

used throughout. Baicalein was purchased from Aldrich Chem. Co. (Milwaukee,
WI); crocetin from MP Biomedicals, LLC (Solon, Ohio); and trans-resveratrol from
Sigma-Aldrich (Oakville, ON, Canada). Schisanhenol (> 99%) was isolated and
purified from plant sources by our collaborator within the Consortium for the
Globalization of Chinese Medicine (CGCM), Professor Daofeng Chen, Fudan
University, Shanghai (Lu and Chen 2009). Dimethyl sulfoxide (DMSO,
Hybri-Max™), Triton® X-100, L(+)-lactic acid, iodonitrotetrazolium chloride (INT),
phenazine methosulfate (PMS) and P-nicotinamide adenine dinucleotide hydrate
from yeast (NAD) were purchased from Sigma-Aldrich (Oakville, ON, Canada).
Lipid Hydroperoxide (LPO) Assay kits (96 well) and Protein Carbonyl
Assay kits were purchased from Cayman Chemical Company (Ann Arbor, MI).
BD Falcon™ 75 or 150cm2 tissue culture flasks, BD Falcon™ 5mL polypropylene
round-bottom tubes, BD Falcon™ 5mL polystyrene round-bottom test tubes,
Falcon® Blue Max™ 50mL polypropylene conical tubes, Falcon® Microtest™ tissue
culture flat-bottom 96-well plates and Falcon® Multiwell™ tissue culture
flat-bottom 12 well plates used for culture of cells were purchased from BD
Biosciences (Mississauga, ON).

3.2

JURKAT E 6 .1 CELL LINE
The Jurkat cell line was initially established from the peripheral blood of a

14 year-old-boy (Schneider, Schwenk et al. 1977). The Jurkat E6.1 cells (human
leukaemic T cell lymphocytes) used throughout this thesis are a clone of the Jurkat
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-FHCRC line, derived from the original Jurkat cell line (Weiss, Wiskocil et al.
1984). The Jurkat £6.1 cell line was obtained from the American Type Culture
Collection (ATCC), reference #TIB-152 (http://www.atcc.org).

3.3

CELL CULTURE AND CELL PREPARATION
The Jurkat £6.1 culture medium was prepared by dissolving 16.2 g RPMI

medium 1640 (containing 2 mM L-glutamine, lOmM HEPES, ImM sodium
pyruvate, 4.5 g/L glucose, and 1.5 g/L sodium bicarbonate) powder in 1 L distilled
water, then add 2g NaHC03 and adjust pH of medium to 7.2. Cell culture medium
was filtered in the fume hood to remove undissolved particles. The prepared Jurkat
£6.1 medium was kept in the 4 °C refrigerator until it is used for cell culture and
experiments. The Jurkat £6.1 cell line was maintained in BD Falcon™75 cm2 or 150
cm tissue culture flasks in the incubator with humidified atmosphere at 37 ± 0.5 °C
and 5% CO2. Cell concentrations were maintained between 1x10s and lxlO6
cells/mL. Cultures were maintained by adding the fresh medium or replacement of
medium every 2 to 3 days.
All the cell culture work and cell preparation for experiments were performed
in a sterile laminar flow hood at room temperature. Prior to the use of Jurkat £6.1
cells for experiments, cell medium was brought up for 30min until it reached to
room temperature (20-26 °C). Cells were transferred to Falcon® Blue Max™ 50mL
polypropylene conical tubes and centrifuged at 500 x g (1,500 rpm) using a S4180
Rotor with a Beckman GS-15R centrifuge for lOmin. The supernatant was then
discarded, and pellet was washed with 50mL phosphate buffered saline buffer
(lxPBS; 1.15% Na2HP04, 0.2% KH2P04, 8.0% NaCl, 0.2% KC1, pH7.4) and
centrifuged again in the same condition. After that, cells were resuspended in cell
culture media to the desired cell density.
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3.3.1

Trypan Blue Exclusion Assay
Trypan blue is a vital stain that used for viable cell counting (Phillips and

Terryberry 1957). The principle of this assay is that live cells exclude the trypan
blue dye using energy-dependent membrane pumps, while dead cells are stained
blue due to dye inclusion, which is basis for the differential staining which enables
visualization to determine viable versus non-viable cells.
0.4% trypan blue solution and a hemocytometer were used to determine total
cell counts and viable cell number. A cell suspension-trypan blue mixture was
prepared by mixing the same volume of cell suspension and trypan blue solution,
and allowing the mixture to stand for 5 min. With the cover-slip in place, Pasteur
pipette was used to transfer a small amount of the cell suspension-blue mixture to
both chambers of a hemocytometer by carefully touching the edge of the cover-slip
with the pipette tip, and allowing each chamber to fill by capillary action. Cells were
then counted starting with the top and left at perimeter of each square, cells touching
the middle line at bottom and right sides were excluded from the count. The
procedure was repeated for the centre square and four comer squares of both
chambers.
The cell concentration per mL was determined using the following
calculation:
Cells per mL = the average count per square x dilution factor x 104 (count 10
squares)
3.4
3.4.1

DRUGS
N-Hydroxyl-sulfamethoxazole
The synthesis of A-Hydroxyl-suifamethoxazole (SMX-HA, IUPAC:

4-(hydroxyam ino)-A-5 -methyl-1,2-oxazol-3 -y l)benzenesulfonamide,
MW:269.2784) was according to the the method of (Rieder, Uetrecht et al. 1988).
SMX-HA prepared by Dr. Michael Kerr at the University of Western Ontario

showed the purity >99% under high performance liquid chromatography (HPLC),
mass spectrometry, and nuclear magnetic resonance analysis.
3.4.2

Baicalein
Baicalein (BE, IUPAC: 5,6,7-trihydroxy-2-phenylchromen-4-one, MW:

270.24) is a major flavonoid isolated from the root of Scutellaria baicalensis (Liu,
Wu et al. 2010). BE is yellow crystalline solid and possess low water-soluble
ability. Before each experiment, BE was dissolved in small amount of DMSO and
then diluted with the appropriate cell culture medium. Before each experiment so
that all TCM constituents could be treated identically. BE was freshly prepared for
each experiment. The final concentration of DMSO in the cell culture medium did
not exceed 0.2%.

3.4.3

Crocetin
Crocetin

(Cro,

IUPAC:

(.2E,4E,6E,8E,10E,12E,14E)-

2,6,11,15-Tetramethyl- 2,4,6,8,10,12,14- hexadecaheptaenedioic acid, MW: 328.4)
is an active carotenoid that is found in the crocus flower (Shen, Qian et al. 2009).
Cro was freshly prepared before each experiment. Briefly, Cro was dissolved in
small amount of DMSO and then diluted with the appropriate cell culture medium.
The final concentration of DMSO in the cell culture medium was maintained at
0.2% .
3.4.4

Resveratrol
7><ms-resveratrol (Res, IUPAC: (£)-5-(4-hydroxystyryl)benzene-l,3-dioI,

MW: 228.24) is a natural polyphenolic phytolexin isolated from the roots of white
hellebore and found in red grapes and red wine (Das and Das 2007). The white
powder with slight yellow cast was freshly dissolved in DMSO, and then diluted in
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the appropriate cell culture medium or buffer prior to each experiment. The final
concentration of DMSO used in the cell culture did not exceed 0.2%.
3.4.5

Schisanhenol
Schisanhenol (Sal, IUPAC:5,6,7,8-tetrahydro-2,3,10,l 1,12-pentamethoxy-

6,7-dimethyldibenzo(a,c)cycloocten-l-ol, MW: 402.45) is a dibenzocyclooctene
lignan derived from the ripe fruits of Schisandra plants (Zhang, Lin et al. 1995). A
schisanhenol stock solution was freshly prepared by first dissolving the white
powder in DMSO and then diluting with the appropriate cell culture medium prior
to each experiment. The final concentration of DMSO in the cell culture medium
was never more than 0.2%.

3.4.6

Mixture 1
Synthetic mixture 1 was an equimolar mixture prepared so that a 1 pM

solution was 0.25 pM for each of BE, Cro, Res, and Sal, providing a final
combined concentration of 1 pM. The ingredients were initially dissolved in
DMSO, and then diluted in the appropriate cell culture medium. The final
concentration of DMSO used in the cell culture medium was never more than
0 . 2% .

3.4.7

Mixture 2
Synthetic mixture 2 was an equimolar mixture of BE, Cro and Res

prepared so that a 1 pM solution of final incubation mixture contained 0.33 pM
BE, Cro and Res, equivalent to a final concentration of lpM. This mixture was
freshly prepared by first dissolving the powder in DMSO and then diluting with
the appropriate cell culture media or buffer. The final concentration of DMSO in
the cell culture medium was never more than 0.2%.
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3.5

TREATMENT OF JURKAT £6.1 CELLS
One of the objectives of this thesis was to determine the effects of

individual and combined constituents of TCM on the redox status of Jurkat £6.1
cells alone, to test for any cytotoxic effects. In addition, an important objective was
to determine the cytoprotective activity of these TCM constituents, alone and in
combination, against the cytotoxicty of the electrophilic and reactive metabolite of
SMX, SMX-HA. In short, we set out to determine if antioxidant and
immunomodulant BE, Cro, Res or Sal, which act by different antioxidant
mechanisms, could protect against the cytotoxicity of SMX-HA, a known source
of oxidative and nitrosative stress. We also evaluate the lowest concentration
(range) over which these compounds are cytoprotective.
Jurkat £6.1 cells were transferred to Falcon® Blue Max™ 50 mL
polypropylene conical tubes and centrifuged at 500 x g (1,500 rpm) using a S4180
Rotor with a Beckman GS-15R centrifuge for 10 min. The supernatant was then
discarded, and pellet (cells) was washed with 50 mL PBS buffer and centrifuged
again in the same condition. After that, the supernatant was discarded and the cells
were resuspended in RPMI-1640 medium supplemented with P/S, and the cell
density was adjusted to 5><105 cells/mL. Cells were routinely divided into multiple
groups for individual experimental treatments and were seeded at 1*105 cells/well
in triplicate for each group in Falcon® Microtest™ tissue culture flat-bottom
96-well plates. All test incubations were conducted at 37 °C in a 5% CO2
humidified environment, and all experiments were repeated at least 3 times by
using different cell cultures in each time.
To test the cytotoxicity effects of the various TCM constituents alone and
in combination on Jurkat £6.1 cells, cells were incubated with different
concentrations (from 6.25 pM to 400 pM) of BE, Cro, Res, Sal, mixture 1, and
mixture 2 for 6 h and 24 h, then the level of released of LDH was compared to
cells treated with RPMI-1640 medium supplemented with P/S (control) for 6 h and
24 h; with 0.2% DMSO in RPMI-1640 medium supplemented with P/S (vehicle
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control) for 6 h and 24 h; and with 2% Triton X-100 (high control) for 6 h and 24
h.
Subsequently, individual group of cells were pretreated either with
RPMI-1640 medium supplemented with P/S (control); with 0.2% DMSO in
RPMI-1640 medium supplemented with P/S (vehicle control); with 2% Triton
X-100 (high control); or with 1 or 5 pM of BE, Cro, Res, Sal, synthetic mixture 1
(equimolar mixture of BE, Cro, Res and Sal) or synthetic mixture 2 (equimolar BE,
Cro and Res) for 30 min followed by incubation with 0 or 400pM SMX-HA for 2
h. As described before, all the TCM and drug solutions were freshly prepared in
DMSO immediately before each experiment was performed. The individual assays
are described in more detail below.

3.5.1

Measurement of Cell Membrane Damage by Release of Lactate

Dehydrogenase
Lactate dehydrogenase (LDH) is a stable cytoplasmic enzyme that is present in
many different types of cells, including plants and animals (Vanderlinde 1985). It
is rapidly released into the cell culture supernatant if the cell membrane is
damaged or ruptured, so that an increased release of LDH is generally attributed to
cellular damage. The LDH release assay is a sensitive measure for cytotoxicity
first used by Korzeniewski and Callewaert (1983).
Cytotoxicity was determined by measuring the LDH activity released into the
cell free supernatants using a colorimetric assay. The increased level of LDH
enzyme in the culture supernatant was mediated by the increased numbers of dead
or plasma membrane-damaged cells under cytotoxicity effects. LDH leakage in the
cell culture supernatant reduces iodonitrotetrazolium chloride (INT) to the
formation of formazan via several steps of enzymatic reaction (Korzeniewski and
Callewaert 1983). After a period of time, the formation of formazan induced the
color change of cell culture supernatant. The amount of formed color is

proportional to the number of lysed cells. The formazan dye formed is water
soluble and shows a broad absorption maximum near 500 nm.
The level of released of LDH into cell culture supernatant was used to
evaluate the effects of BE, Cro, Res and Sal, alone and in combination on the
membrane of Jurkat £6.1 cells in a time- and concentration-dependent manner. We
use medium control incubations to measure any interfering factors contained in the
assay medium. Also, medium control can be used to correct for other treatment
groups to exclude any interfering factors which may influence the result. The low
control incubation reflects spontaneous LDH release from untreated normal cells
in the absence of any chemicals. The values of high control were obtained from
cells that treated with 2% triton X-100 solution. Triton X-100 is a nonionic
surfactant that can lyse cells. The incubation with 2% triton X-100 solution
provided insight into the total LDH content of the cells (100% LDH release).
Substrate controls (added at the end of the incubation period, immediately before
analysis) provided information about any interference of the test substances (BE,
Cro, Res and Sal) with the assay for LDH activity.
Jurkat £6.1 cells were washed in 1 x PBS and resuspended in assay
medium [RPMI-1640 medium supplemented with 0.2% (v/v) BSA]. The cell
seeding density has great effect on the absorbance difference between spontaneous
LDH release and maximum LDH release. The optimal cell density was determined
to be at 2><105 cells per mL for 6 h incubation, and 3><105 cells per mL for 24 h
incubation experiments. For the leakage of LDH assay, cells were plated in
triplicate into Falcon® Microtest™ tissue culture flat-bottom 96-well plates in
assay medium. Cells were treated with BE, Cro, Res, Sal, mixture 1, and mixture 2
for both 6 and 24 h. The concentrations of constituents of TCM used were 6.25, 25,
50, 100, 200 and 400 pM. The whole incubations were performed at 37°C and in a
5% CO2 humidified environment. After treatment for 6 or 24 h, Falcon®
Microtest™ tissue culture flat-bottom 96-well plates were centrifuged at 500 x g
for 10 min. 100 pL of cell culture supernatant were carefully transferred from each
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well to a new Falcon® Microtest™ tissue culture flat-bottom 96-well plate. 100 pL
of substrate mixture (LACTATE 54 mM, INT 660 pM, PMS 280 pM, NAD 1.3
mM) was freshly prepared (pH= 8.2) and added into the supernatant in each well.
The mixtures were incubated at room temperature on rocking table for 20 min,
protected from light. The absorbance of the samples was measured by a Tecan
Microplate Reader at a wavelength of 490 nm. The absorbance values were
collected using the XFluor 4 program.
To determine the percentage LDH release, the average absorbance values
of triplicate incubations were calculated and corrected for background control
absorbance. The resulting values are substituted in the following equation:
LDH Release (%) =

exp. value - low control

x 100%

high control - low control

3.6

TREATMENT OF JURKAT E6.1 CELLS WITH BAICALEIN,

CROCETIN, RESVERATROL OR SCHISANHENOL SINGLY AND IN
EQUIMOLAR MIXTURES IN COMBINATION WITH THE CYTOTOXIC
SULFAMETHOXAZOLE (SMX) METABOLITE, SMX-HA

3.6.1

Measurement of Cell Viability by Release of Lactate Dehydrogenase
One of the objectives of this thesis was to determine the effects of

individual and combined constituents of TCM on the viability of Jurkat £6.1 cells
also treated with the electrophilic and reactive metabolite of SMX, SMX-HA.
Therefore,

we

were

interested to

determine

if the

anti-oxidants and

immunomodulants BE, Cro, Res or Sal, which act by different complementary
mechanisms, could protect against the cytotoxicity of SMX-HA, and the
concentration range over which these compounds are cytoprotective.
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Jurkat £6.1 cells were washed, resuspended in RPMI-1640 medium
supplemented with P/S, and the density adjusted to 5><105 cells per mL. Cells were
divided into individual groups and were seeded at lxlO5 cells per well triplicate in
each group in Falcon® Microtest™ tissue culture flat-bottom 96-well plates. A
vehicle control group (0.2% DMSO in RPMI-1640 medium supplemented with
P/S) was included in each experiment. Cells were pretreated with 5 or 20 pM of
BE, Cro, Res or Sal, or synthetic mixture 1 or synthetic mixture 2 for 30 min. After
that, some cells were treated with 0.2% DMSO in RPMI-1640 medium
supplemented with P/S (vehicle control) for 2 h; others were treated with 400 pM
of SMX-HA for 2 h; and the final group of cells was incubated with 400 pM of
SMX-HA for 2 h. All incubations were at 37 °C and in a 5% CO2 humidified
environment. All drugs were freshly prepared in DMSO and RPMI-1640 medium
supplemented with P/S as described above. The percentage of LDH release was
also determined as described above.

3.6.2

Analysis of Lipid Peroxidation
Lipid is one of the important structural components of cell membrane and

lipids are primary targets of oxidized modification by free radicals, mainly due to
the unsaturated lipids in membranes (McIntyre and Hazen 2010). Lipid
peroxidation changes the structure and function of membrane lipids. Also, lipid
peroxidation results in the formation of highly reactive and unstable
hydroperoxides of both saturated and unsaturated lipids. The Lipid Hydroperoxide
Assay Kit (705003 with glass 96-well plate and 705002 without 96-well glass plate)
supplied by the Cayman Chemical Company measures hydroperoxides directly
(Mihaljevic, Katusin-Razem et al. 1996). Hydroperoxides are unstable and react
readily with ferrous ions to produce ferric ions. The resulting ferric ions are
detected using the thiocyanate ion as the chromogen. There were two factors that
might influence the result. Firstly, samples may contain ferric ions and thus cause
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the over-estimation of the result. In addition, H20 2 in biological samples also react
with ferrous ions and cause the higher level of lipid hydroperoxide. These potential
problems can be prevented by performing studies in chloroform.
Jurkat £6.1 cells were washed with I x PBS, resuspended in assay medium
[RPMI-1640 medium supplemented with 0.2% (v/v) BSA]. Cell density was
adjusted to 5xl 05 cells per mL. Cells were divided into individual groups and were
seeded at 5*105 cells per well, in quadruplicate, for each group in Falcon®
Multiwell™ tissue culture flat-bottom 12-well plates. A vehicle control group
(0.2% DMSO in RPMI-1640 medium supplemented with P/S) was included in
each experiment. Cells were pretreated with 5 or 20 pM of BE, Cro, Res or Sal, or
synthetic mixture 1 or synthetic mixture 2 for 30 min. After that, some cells were
treated with 0.2% DMSO in RPMI-1640 medium supplemented with P/S (vehicle
control) for 2 h; others were treated with 400 pM of SMX-HA for 2 h; and the
final group of cells was incubated with 400 pM of SMX-HA for 2 h.
After the 2.5 h incubation, cells from each well were transferred to
corresponding 1.7 mL micro-centrifuge tubes, centrifugation at 500*g (F2402
Rotor with a Beckman GS-15R centrifuge) for 10 min, supernatant (drugs) were
removed. Cells were resuspended in lmL of RPMI-1640 medium supplemented
with FBS and P/S, returned to the plates, and incubated for 18h at 37 °C and in a
5% C 02 humidified environment.
After 18 h incubation, cells were transfered into glass test tubes and
sonicated in 500pL HPLC-grade water. An equal volume of Extract R saturated
methanol solution (100 mg of Extract R solid was added into 15 mL methanol and
vortex thoroughly 2 min) was added to each tube and tubes were vortexed. One
mL of cold deoxygenated chloroform (chloroform was deoxygenated by bubbling
nitrogen for at least 30 min) was added to each tube and vortexed thoroughly.
Tubes were then centrifuged at 500xg using the S4180 Rotor with a Beckman
GS-15R centrifuge for 5 min at 0°C. The bottom chloroform layer was then
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collected and transferred into a another glass test tube by carefully inserting a
Pasteur pipette along the side of the test tube, and stored at -80 °C.
Standards for the assay were prepared by aliquoting Lipid Hydroperoxide
Standards

(HP)

[containing

50

pM

ethanolic

solution

of

13-hydroperoxy-octadecadienoic acid (13-HpODE)] and deoxygenated (2:1)
chloroform-methanol mixture in triplicate to 12x75 mm borosilicate glass tubes.
500 pL of the chloroform extract of each sample were transferred to appropriately
labeled

12x75

mm borosilicate

glass tubes.

Next,

450

pL of (2:1)

chloroform-methanol solvent mixture were added to the sample test tubes. The
chromogen was prepared by mixing equal volume of FTS Reagent 1 (containing
4.5mM ferrous sulphate in 0.2M hydrochloric acid) and FTS Reagent 2
(containing a 3% methanolic solution of ammonium thiocyanate) in test tube and
vortex. We then prepared 50 pL of the freshly prepared chromogen for each assay
tube and vortexed them thoroughly. The test tubes were closed tightly with
polypropylene caps. The assay tubes were kept at room temperature for 5 min,
letting the reaction to proceed. Finally, 300pL from each sample or standard tube
was transferred into the glass 96-well plate. Each sample was assayed in triplicate.
The plate was covered with aluminum foil cover to avoid evaporation from the
wells and absorbance was read at 500 nm.

3.6.3

Analysis of Protein Carbonyl Content
Proteins are major targets for free radicals and other oxidants. Protein

carbonylation to aldehydes or ketones is a major modification of proteins resulting
from oxidative stress (Dalle-Donne, Rossi et al. 2003). Carbonyl groups are
generated on protein side chains through oxidation of Lys, Arg, Pro or Thr
residues, an irreversible modification that frequently results in loss of function
(Dalle-Donne, Scaloni et al. 2005).
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Protein carbonyl content was analyzed as a general biomarker for protein
oxidation to evaluate the attenuation of preincubation of Jurkat £6.1 cells with
TCM constituents, alone or in combination, on SMX-HA-mediated protein
oxidation. The Caymen Chemical Protein Carbonyl Assay Kit (10005020) utilizes
the 2,4-dinitrophenylhydrazine (DNPH) reaction to measure the protein carbonyl
content. The DNPH reagent reacts with protein carbonyls, forming a Schiff base to
produce the corresponding yellow 2.4-dinitrophenylhydrazones, which are
analyzed spectrophotometrically (Levine, Williams et al. 1994). The amount of
protein-hydrazones produced is quantified by their absorbance at 360nm.
Cell preparation and treatment were exactly as described for the assay of lipid
hydroperoxides (above). After drug removal and subsequent incubation for 18 h at
37 °C in a 5% CO2 humidified environment, cells were divided and transferred to
two 100 pL aliquots in 1.7 mL microcentrifuge tubes. One tube was the sample
tube and the other the control tube. 400 pL of DNPH regent was added to the
sample tubes, while 400 pL of 2.5 M HC1 was added to the control tubes. Both
tubes were incubated in the dark at room temperature for 1 h. Each tube was
vortexed briefly every 15 min during the incubation. After 1 h, 0.5 mL 20%
trichloroacetic acid (TCA) was added to each tube and vortexed thoroughly. The
tubes were placed on ice and incubated for 5 min. The tubes were then centrifuged
at 10,000xg for 10 min at 4 °C to form protein pellet. The supernatant was then
discarded and the pellet was resuspended in 0.5 mL 10% TCA solution. The tubes
were then placed on ice for 5 min and were then re-centrifuged at 10,000* g for 10
min at 4 °C. The supernatant was removed, and the pellet was resuspended in 0.5
mL ethanol/ethyl acetate mixture (1:1). The pellet was manually suspended and
vortexed thoroughly and then centrifuged at 10,000*g for 10 min at 4 °C. The
wash step was repeated twice after the final wash, protein pellets were resuspended
in 500 pL guanidine hydrochloride and vortexed. The tubes were again centrifuged
at 10,000xg for 10 min at 4 °C to remove any remaining debris. 220 pL of the
supernatant from the sample tubes and 200 pL of the supernatant from the control
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tubes were transferred to a 96-well plate, and both sample tubes and control tubes
were assessed in duplicate. The absorbance was measured at 360 nm using a Tecan
Microplate Reader.
To determine the protein carbonyl content, the average absorbance of each
sample and control was determined, and the corrected absorbance (CA) was
calculated by subtracting the average absorbance of the controls from the average
absorbance of samples. The concentration of the carbonyls was then determined
using an extinction coefficient of 22,000 M'1 (Dirmeier, O'Brien et al. 2004).

3.6.4

Analysis of the protein-protein mixed disulfides, a major component of

the disulfide proteome by Redox Two-Dimensional Page (R2D SDS-PAGE)
Prior to treatment, Jurkat £6.1 cells were washed in 1 XPBS, resuspended in
RPMI-1640 medium supplemented with P/S, and the density adjusted to 8x 105
cells per mL. Cells were seeded at 8><105 cells/mL (2 mL/well) in 6-well tissue
culture plates to yield sufficient protein for analysis by R2D PAGE. Jurkat £6.1
cells were pretreated by incubation with 0, 1 or 5 pM of each of BE, Cro, Res or
Sal, alone or in combination for 30 min, followed by treatment with 0 or 400 pM
SMX-HA for 2 h. All incubations were conducted at 37 °C and in a 5% CO2
humidified environment. All drugs were freshly prepared in 0.2% DMSO and
RPMI-1640 medium supplemented with P/S just before each experiment.
After the 2 h incubation, cells were collected in 2 mL micro-centrifuge tubes,
by centrifugation of cells and culture medium at 500xg (F2402 Rotor with a
Beckman GS-15R centrifuge) for 5 min. Cell pellets were re-suspended in PBS
and re-centrifuged for 5 min at 500 xg. Then, cells were resuspended in cold PBS
and treated with 40 mM iodoacetamide (IA) for 5 min to derivatize free cysteine
protein thiol groups to prevent thiol-disulfide exchange and inhibit post-lysis
oxidation of free cysteine thiols (Cumming, Andon et al. 2004). After IA
incubation, samples were centrifuged again at 500 xg for 5 min and cell pellets
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were resuspended in 50pL lysis buffer (one protease inhibitor cocktail tablet from
Roche Diagnostics GmbH, Indianapolis, ESI, added to 9 mL lysis buffer, composed
of 7.44 mg EDTA, 0.12 g Tris, 0.76 g NaCl, 0.159 g NaH2P04- 1H20, 0.446 g
Na4P207* 10H2O, 0.042 g NaF dissolved in 100 mL water) and quickly frozen in
liquid nitrogen. The lysates were thawed in a water bath at room temperature, then
centrifuged for 10 min at 14,000xg (F2402 Rotor with a Beckman GS-15R
centrifuge), and the supernatant fractions were collected and transferred to new
tubes. An aliquot was removed for assay of protein content by the Bradford assay,
as described below.
The dye reagent was prepared by diluting 5x dye reagent concentrate 4:1 with
water and filtrated through a filter paper. The protein standard was prepared by
aliquot mixing the bovine serum albumin (BSA) (lmg/mL) and distilled water. 10
uL of protein standard and protein supernatant fractions were plated in triplicate in
96-well plate. 200 uL of diluted dye reagent was added to each well, which was
then left on a moving table for 10 minutes. The absorbance was measured at 570
nm using a Tecan Microplate Reader. Finally, the standard curve was made and
was used to calculate unknown protein concentration.
The gels for analysis in the first dimension (10% acrylamide, 1.0 mm thickness)
were prepared using the procedure of (Cumming, Andon et al. 2004). The same
volume (less than 50 pL) of protein extract (containing equal volume of SDS
sample buffer, different volumes of distilled water, and 85 pg of the harvested
cytosolic protein) were subjected to 10% non-reducing SDS-PAGE electrophoresis
for 3 h, using a constant current of 24 mA/gel with a Bio-Rad Protean II apparatus.
The different gel lanes contained proteins for each individual treatment. After the
first-dimension electrophoresis, each gel lane containing the separated proteins for
each treatment was then cut and put in an individual glass dish. Then each gel lane
was immersed and reduced using 10 mL SDS sample buffer containing 100 mM
DTT and the plates were left on the rocking table for 20 min at room temperature.
Following 3 washes with lxSDS running buffer (1 min/time), each gel lane was
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incubated in 10 mL SDS sample buffer containing lOOmM IA on the rocking table
for 10 min at room temperature. Each gel lane was then placed horizontally on top
of the second-dimension gel (10% acrylamide, 1.5 mm thickness), fixing and
sealing each gel strip using 2 mL of boiled 2% low melt agarose buffer.
Electrophoresis was then performed in the second dimension for 14 h at a constant
current of 10 mA/gel (Cumming, Andon et al. 2004). After the second
electrophoresis, the gels slabs were removed and put into a Dodeca small Stainer
(Bio-Rad) for silver staining. Each gel slab was initially fixed using a 50:50
mixture of water and methanol for 30 min. The gels were then washed twice (5
min/each) with distilled water to remove residual methanol. After that, the gels
were incubated in sensitizer solution (0.02% sodium thiosulfate) for 5 min.
Following two washing with distilled water for 1 min each, the gel slabs were
immersed in cold 0.2% silver nitrate solution and incubated for 30 min. Then the
gel slabs were rinsed with distilled water twice for 1 min, and were developed in
solution containing 0.05% formaldehyde and 3% sodium hydroxide. The staining
step was stopped after the developer solution turned yellow and the desired
intensity of staining. After staining the gel, proteins that do not contain any
disulfide bond form a diagonal line; proteins that are linked by an intermolecular
disulfide bond are found at the right side of the diagonal line; proteins that form
intramolecular disulfide bonds are found on the left side of the diagonal line (Fig
8). A shows the majority of proteins that does not form disulfide bonds which
represents in diagonal line. B C E lie on the right of the diagonal line. These
proteins that form intermolecular disulfide bonds exhibit a slower electrophoretic
mobility under non-reducing conditions in the first dimension. D F appear to the
left of the diagonal line represent proteins that exhibit a faster electrophoretic
mobility under non-reducing conditions due to intra-molecular disulfide bonding.
Here are some difference between B C and E, B and C are heterodimeric which
will be separated in second dimension while E is homodimeric only represent one
spot in second dimension.
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The development step was stopped and followed by submerging the gel slabs
in 5% acetic acid (Shevchenko, Wilm et al. 1996). Finally each gel slab was
scanned prior to analysis of resolved proteins.

Figure 8.

Image of R2D-PAGE result
(adapted from Biteau, B.et al. 2003. Nature 425, 980-984)
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3.7

STATISTICAL ANALYSIS
Statistical evaluation of data was done by analysis of variance (ANOVA)

followed by Bonferroni’s multiple comparison post test used to test for statistical
differences between groups. A probability of more than 95% (P<0.05) was
considered to be statistically significant. Student’s r-test was used in some cases to
compare the vehicle control and treatment groups. All experiments were repeated
at least 3 times with different cell cultures. Error bars represent mean ± SEM (N =
at least 3). GraphPad Prism Version 5.01 (GraphPad Software, Inc) was used for
statistical analyses.
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CHAPTER 4:
4.1

RESULTS

CELL TREATMENTS-BAICALEIN, CROCETIN, RESVERATROL

AND CHISANHENOL EXPOSURE ALONE AND IN COMBINATION
4.1.1
4.1.1.1

Cell Viability
Lactate Dehydrogenase (LDH) Release
As a method to measure cell viability, LDH release assay was employed to

determine concentration- and time-dependent effects of BE, Cro, Res and Sal
singly and in combination on Jurkat £6.1 cells. Jurkat E6.1 cells were incubated
for 6 and 24 h with indicated concentrations of these four chemicals.
Jurkat £6.1 cells were incubated with 6.25, 25, 50, 100, 200, or 400 pM of
BE, Cro, Res, Sal, Mixture 1, and Mixture 2 for 6 h. The comparative ability of the
various treatments to induce LDH in Jurkat £6.1 cells is summarized in Table 3.
At 6 h incubation, BE at concentration 50 pM showed a significant
increase (P<0.05) in LDH release compared to control, and LDH leakage is further
increased at higher concentration. Cro treated cells showed a significant increase
(P<0.05) in LDH release starting at concentration above 25 pM, which further
increased at higher concentrations. Res at concentration above 50 pM (P<0.05)
causes significant increase in LDH release, and further increased with increasing
concentrations. Sal induced significant LDH release starting at concentration 100
pM (P<0.05) compared to control, which further increased at 200 and 400 pM.
Similar to Sal, mixture 1 starting at concentration 100 pM (P<0.05) showed
significant increase in LDH release, which further increased at higher
concentration.

Among these single chemicals and mixtures,

mixture 2

demonstrated the lowest cytotoxicity, with significant increases in LDH leakage
starting at 200 pM.
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Table 3. Effect of Baicalein, Crocetin, Resveratrol, Schisanhenol and the
mixtures on the Release of Intracellular Lactate Dehydrogenase from Jurkat
£6.1 Cells Following Incubation for 6 h

Mixture 1 is an equimolar mixture of Baicalein, Crocetin, Resveratrol and
schisanhenol
Mixture 2 is an equimolar mixture of Baicalein, Crocetin and Resveratrol
*P<0.05, individual treatment vs 0 pM control
#P<0.05, within concentration comparisons to mixture 2, the lowest release of
LDH at highest concentration tested.

R e le a s e o f L a c t a t e D e h y d r o g e n a s e
( % T o ta l C e llu la r L D H ; M e a n ± S E M , N = 3 )
100 n M

2 0 0 ¿iM

4 0 0 fiM

3.1 (.0 6 )* #

3 .9 (0 .1 )* #

4 .6 (0 .1 )* #

6 .9 (0 .3 )*

1.9 (.0 9 )* #

3 .0 (0 .1 )* #

4 .6 (0 .1 )* #

7 .3 (.0 6 )* #

1 3 .8 (0 .2 ) * #

-0 .4 (.0 5 )

0 .7 (.0 8 )

1.1 (.0 5 )* #

3 .4 (0 .1 )* #

4 .7 (0 .1 )* #

8 .9 (.0 5 )* #

S c h isa n h e n o l

-0 .3 (.0 3 )

-0 .2 (.0 9 )

0 .2 (0 .1 )

2 .8 (0 .2 )*

1 4 .9 ( 0 .3 ) * #

2 6 .8 (0 .3 )* #

M ix tu re 1

.03 ( .0 0 7 )

0 .6 (0 .1 )

2 .3 (0 .1 )#

3 .6 (0 .1 )* #

6 .8 (0 .1 )* #

12.8 (0 .2 )* #

M ix tu re 2

-0 .5 (.0 2 )

-0 .3 (.0 3 )

.0 4 (.0 0 2 )

0 .4 (.0 3 )

1.5 (.0 1 )*

3 .3 (0 .1 )*

C om pound

6 .2 5 \iM

2 5 ¡iM

B a ic a l e in

1.1 (.0 5 )#

1.6 (0 .1 )#

C ro c e tin

1.2 ( .0 3 )#

R e s v e ra tro l

50

ji M

Next, Jurkat £6.1 cells were incubated with 6.25, 25, 50, 100, 200, or 400
pM of BE, Cro, Res, Sal, Mixture 1, and Mixture 2 for 24 h. The comparative
ability of the various treatments to induce LDH in Jurkat £6.1 cells is summarized
in Table 4.
At 24 h incubation, BE starting at concentration 50 pM caused a significant
increase (P<0.05) in LDH release compared to control, and LDH leakage is further
increased with increasing concentrations. Low concentrations of Cro also induced
significant increases (P<0.05) in LDH release. Res at concentration higher 100 pM
(P<0.05) causes significant increase in LDH release, which further increased at
200 and 400 pM. Sal induced significant LDH release starting at concentration 100
pM (P<0.05) compared to control, however, at 200 and 400 pM, Sal caused more
release of LDH than other single chemicals. Mixture 1 starting at concentration
100 pM (P<0.05) produced significant leakage in LDH release, which further
increased at higher concentration. Similar with 6 h incubation, mixture 2 at 24 h
also exhibits the lowest cytotoxicity.
Antioxidants are in fact redox (reduction-oxidation) agents. They are normally
studied at low concentrations to the goal of protecting against free radicals in some
circumstances, thus avoiding their potential toxic (pro-oxidative) effect at higher
concentrations. We used LDH release as the end-point and a biomarker to
determine the concentration- and time-dependent cytotoxicity for these four
chemicals alone and in combination. From these results, Sal produced higher
cytotoxicity than the other single constituents at the highest concentration studied
(400 pM). This property of Sal also exerts an influence on the mixtures, in that
mixture 1 showed more cytotoxicity effect than mixture 2.

Table 4. Effect of Baicalein, Crocetin, Resveratrol, Schisanhenol and the
mixtures on the Release of Intracellular Lactate Dehydrogenase from Jurkat
£■6.1 Cells Following Incubation for 24 h

Mixture 1 is an equimolar mixture of Baicalein, Crocetin, Resveratrol and
Schisanhenol
Mixture 2 is an equimolar mixture of Baicalein, Crocetin and Resveratrol
*P<0.05, individual treatment vs 0 pM control
#P<0.05, within concentration comparisons to mixture 2.
R e le a s e o f L a c ta t e D e h y d r o g e n a s e
(% T o ta l C e llu la r L D H ; M e a n ± S E M , N =3)

C om pound

6 .2 5 iiM

25 jiM

5 0 ¡iM

100 jiM

2 0 0 jiM

4 0 0 ¡iM

B a ic a le in

1.8 (0 .2 )

3.3 (0 .2 )

13.1 (0 .8 )* #

1 8 .0 (0 .5 )* #

2 1 .7 (0 .5 ) * #

2 7 A (0 .8 )* #

C ro c e tin

1.1 (.0 5 )* #

2.1 (.0 5 )* #

3.1 (0.1)*

5 .2 (.0 4 )* #

9 .7 (0 .1 )* # '

2 0 .8 (0 .5 )* #

R e s v e ra tro l

-0 .9 (.0 3 )#

-0 .5 (0 .1 )#

0.1 (.0 6 )#

0 .7 (.0 2 )* #

3 .9 (0 .1 )*

2 7 .6 (0 .2 )* #

S c h is a n h e n o l

-0 .2 (.0 0 4 )

0 .9 (.0 1 )

4 .9 (.03)*

10.2 (.0 6 )* #

2 3 .6 (.0 8 )* #

3 5 .6 (.0 3 )* #

M ix tu re 1

0 .8 (.0 3 )#

1.6 (.0 7 )

2 .7 (.0 6 )*

4 .4 (.0 3 )* #

9 .4 (0 .1 )* #

19.5 (0 .2 )* #

M ix tu re 2

.01 (.0 0 4 )

0 .9 (.004)*

1.8 (.04)*

3 .0 (.0 6 )*

4 .7 (.0 7 )*

11.4 (0.1)*
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4.2

CYTOTOXICITY OF SULFAMETHOXAZOLE

N-HYDROXYLAMINE IN JURKAT E6.1 CELLS AND ITS
ATTENUATION BY BAICALEIN, CROCETIN, RESVERATROL AND
SCHISANHENOL, ALONE AND IN COMBINATION
4.2.1

Cell Membrane Damage
Following exposure of Jurkat £6.1 cells to 400 pM SMX-HA for 2 h

between 35 and 40% of intracellular LDH was released to the medium (Figure 9A)
presumably due to the combined effect of this reactive electrophilic metabolite and
its associated oxidative stress. To evaluate the chemoprotection of the selected
phytochemicals, Jurkat £6.1 cells were exposed to SMX-HA (400 pM) for 2 h
with or without pretreatment with the pure TCM constituents and two synthetic
mixtures for 30 min. The concentrations of the phytochemicals tested were in the
range where there was no enhanced release of LDH relative to control cells after
exposure to the TCM constituents (Tables 3 and 4).
Similar to the initial experiments performed, there was no increase of LDH
release from Jurkat £6.1 cells incubated with 1 or 5 pM BE for 30 min compared
to vehicle-treated control cells (Fig. 9-A). In contrast, treatment of cells with 400
pM SMX-HA damaged the cell membrane, resulting in the release of 38.9 % ±
4.7% (mean ± SEM, N=3) total cellular LDH, a significantly greater release than
in vehicle treated control cells (P0.001). On the other hand, BE at both 1 and 5
pM, partially protected Jurkat cells from SMX-HA-mediated cytotoxicity. More
specifically, BE pretreatment for 30 min decreased the amount of LDH release
subsequent to treatment with SMX-HA (400 pM) for 2 h by 31% and 58% (P<0.05,
vs SMX-HA treated), at the lower and higher doses, respectively (Fig. 9-A). Only
the attenuation at 5 pM was statistically significant but there appeared to be a
dose-response for chemoprotection. Similar concentration-dependent protective
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results were found with the other antioxidant chemicals selected for study,
demonstrating that the strategy used for identification of these antioxidants was
successful and the concentration range selected for study is relevant.
Following preincubation for 30 min at concentrations of 1 or 5 pM and an
additional 2 h in the absence of SMX-HA (negative controls), neither Cro, Res nor
Sal caused detectable membrane damage given that there was no increase in the
amount of LDH released from Jurkat cells relative to vehicle controls (Fig. 9B-D),
identical to the data obtained with BE (Fig. 9-A; Tables 3 and 4). These three latter
compounds appeared to be better chemoprotectants for SMX-HA-mediated
cytotoxicity than BE, given the attenuation of LDH release at the higher
concentration studied (5 pM) was 85% (P<0.01), 80% (P<0.01), and 82% (P<0.01)
for Cro (Fig. 9B), Res (Fig. 9-C) and Sal (Fig. 9-D), respectively compared to 58%
for BE (Fig. 9-A). These three compounds were also more effective at 1 pM than
was BE. Cro seemed to be slightly more effective than either Res or Sal, which
were equipotent at both concentrations although the difference was not significant
(Table 5). At the lower dose, the attenuation of LDH release in SMX-HA treated
cells was 65% (P<0.05) for Cro, compared to 40%, 40% each for Res (P<0.05) and
Sal (P<0.05). Of the compounds tested, only Sal resulted in a small,
concentration-dependent decrease in the amount of LDH released compared to the
solvent control treated cells (Fig. 9-D).
To test our hypothesis that mixtures of pure TCM constituents with diverse
chemical structures and complementary mechanisms for antioxidant activity are
more effective as chemoprotectants than single compounds at equimolar
concentrations, we tested two synthetic mixtures of TCM, prepared based on two
factors. First was the information collected in our cytotoxicity studies (Tables 3
and 4), which showed that Sal was more toxic than the other constituents at the
highest concentration studied (400 pM). Second, based on the fact that Sal will be
more effective as an in vivo antioxidant-immunostimulant than in vitro in Jurkat
E6A

cells due to cytochrome P450-dependent metabolic activation by
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O-demethylation of 5 methoxylated phenolic groups to polyphenols (a reaction
deficient in Jurkat cells) we wished to evaluate two similar mixtures, one with and
one without Sal for eventual comparison in vivo. Mixture 1 was formulated to
contain equimolar amounts (1:1:1:1) of BE, Cro, Res and Sal; and Mixture 2 to
contain equimolar amounts (1:1:1) of BE, Cro and Res.
Treatment with 1 and 5 pM Mixture 1 or Mixture 2 for 30 min plus 2 h did not
increase LDH leakage compared with vehicle control in Jurkat £6.1 cells, a result
anticipated from the cytotoxicity experiments performed (Tables 3 and 4). These
mixtures were comparable in their ability to attenuate SMX-HA-mediated
cytotoxicity to Jurkat £6.1 cells. Thus, LDH release was decreased by pretreatment
with 1 or 5 pM Mixture 1 by 55% (PO.05) and 93% (P<0.01), respectively (Fig
9-E) and by 1 or 5 pM Mixture 2 by 53% (PO.05) and 93% (P<0.05), respectively
(Fig 9-F). The comparative ability of the various treatments to attenuate SMX-HA
cytotoxicity in Jurkat £6.1 cells is summarized in Table 5. When we compared the
attenuation effect of a single constituent, Cro either in 1 or 5 pM exhibit the best
cytoprotective effect, which attenuated SMX-HA mediated LDH release to the
most degree. In addition, pretreatment with 5 pM mixture 1 maximally decreased
SMX-HA induce LDH leakage, which confirmed our hypothesis that the
combination of pure TCM constituents can work through complementary
mechanisms to have a greater protective effect than single component on an
equimolar basis; also, the better chemoprotective effect of mixture 1 is likely
attributable to the presence of Sal, an important contributor of the mixture.
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Figure 9. Effect of pretreatment of Jurkat £6.1 cells with baicalein, crocetin,
resveratrol, schisanhenol, mixture 1, and mixture 2 on the SMX-HA mediated
release of lactate dehydrogenase.

A. Jurkat £6.1 cells were preincubated with 0, 1 or 5 pM BE for 30 min followed
by treatment for 2 h with 400 pM SMX-HA. Data are expressed as mean ±
standard error, N=3 with experiments performed with three different samples of
cultured cells on different days. Significant differences in LDH release were
determined by comparing SMX-HA 400 pM treated cells with all other groups of
cells. Levels of significance are designated by *P<0.05, **P<0.01, or ***P<0.001
relative to SMX-HA 400 pM. In addition, the amount of LDH release in each
group was compared to the vehicle control to identify treatments that differed.
Levels of significance are designated by #P<0.05, # #P<0.01, # # #P<0.001.

B. Jurkat £6.1 cells were preincubated with 0, 1 or 5 pM Cro for 30 min followed
by treatment for 2 h with 400pM SMX-HA. Data are expressed as mean ±
standard error, N= 3 with experiments performed with three different samples of
cultured cells on different days. Significant differences in LDH release were
determined by comparing SMX-HA 400 pM treated cells with all other groups of
cells. Levels of significance are designated by *P<0.05, **P<0.01, or ***P<0.001
relative to SMX-HA 400 pM. In addition, the amount of LDH release in each
group was compared to the vehicle control to identify treatments that differed.
Levels of significance are designated by #P<0.05, # #P<0.01, ## #P<0.001.
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C. Jurkat £6.1 cells were preincubated with 0, 1 or 5 pM Res for 30 min followed
by treatment for 2 h with 400pM SMX-HA. Data are expressed as mean ±
standard error, N= 3 with experiments performed with three different samples of
cultured cells on different days. Significant differences in LDH release were
determined by comparing SMX-HA 400 pM treated cells with all other groups of
cells. Levels of significance are designated by *P<0.05, **P<0.01, or ***P<0.001
relative to SMX-HA 400 pM. In addition, the amount of LDH release in each
group was compared to the vehicle control to identify treatments that differed.
Levels of significance are designated by #P<0.05, # #P<0.01, # # #P<0.001.

D. Jurkat £6.1 cells were preincubated with 0, 1 or 5 pM Sal for 30 min followed
by treatment for 2 h with 400pM SMX-HA. Data are expressed as mean ±
standard error, N= 3 with experiments performed with three different samples of
cultured cells on different days. Significant differences in LDH release were
determined by comparing SMX-HA 400 pM treated cells with all other groups of
cells. Levels of significance are designated by *P<0.05, **P<0.01, or ***P<0.001
relative to SMX-HA 400 pM. In addition, the amount of LDH release in each
group was compared to the vehicle control to identify treatments that differed.
Levels of significance are designated by #P<0.05, # #P<0.01, # # #P<0.001.
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E. Jurkat £6.1 cells were preincubated with 0, 1 or 5 pM Mixture 1 for 30 min
followed by treatment for 2 h with 400pM SMX-HA. Data are expressed as mean
± standard error, N= 3 with experiments performed with three different samples of
cultured cells on different days. Significant differences in LDH release were
determined by comparing SMX-HA 400 pM treated cells with all other groups of
cells. Levels of significance are designated by *P<0.05, **P<0.01, or ***P<0.001
relative to SMX-HA 400 pM. In addition, the amount of LDH release in each
group was compared to the vehicle control to identify treatments that differed.
Levels of significance are designated by #P<0.05, # #P<0.01, # # #P<0.001.

F. Jurkat £6.1 cells were preincubated with 0, 1 or 5 pM Mixture 2 for 30 min
followed by treatment for 2 h with 400pM SMX-HA. Data are expressed as mean
± standard error, N= 3 with experiments performed with three different samples of
cultured cells on different days. Significant differences in LDH release were
determined by comparing SMX-HA 400 pM treated cells with all other groups of
cells. Levels of significance are designated by *P<0.05, **P<0.01, or ***P<0.001
relative to SMX-HA 400pM. In addition, the amount of LDH release in each
group was compared to the vehicle control to identify treatments that differed.
Levels of significance are designated by #P<0.05, # #P<0.01, # # #P<0.001.
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Table 5. Attenuation of the Release of Intracellular Lactate Dehydrogenase
from Jurkat E 6 .1 Cells Following Treatment with 400 pM Sulphamethoxazole
N-hydroxylamine (SMX-HA) for 2 h
Cells were pretreated with 1 or 5 pM of each of the TCM constituents and
Mixtures 1 and 2 for 30 min prior to a 2 h incubation with 400pM SMX-HA
Differences between the amounts of LDH released were determined by Student’s
t-test within each TCM concentration range as a comparison of efficacy of the
various treatments (*P<0.05, vs mixture 1).
Mixture 1 is an equimolar mixture of Baicalein, Crocetin and Resveratrol and
Schisanhenol; Mixture 2 is an equimolar mixture of Baicalein, Crocetin, and
Resveratrol
Attenuation of LDH Release caused by
treatment with 400 p M S M X -H A f o r 2 h
(% d e c re a s e ; m e a n ±

SEM , N =3)

C om pound

1 pM

5 pM

Baicalein

3 0 .9 ± 1 . 2 *

5 7 .5 ± 1 . 9 *

Crocetin

6 4 .9 ± 1 . 9

8 5 .4 ± 0 . 7

Resveratrol

3 9 .9 ± 0 . 9

7 9 .8 ± 0 . 7

Schisanhenol

3 9 .5 ± 2 . 6

8 2 .4 ± 1 . 3

Mixture 1

5 4 .9 ± 1 . 4

9 3 .4 ± 0 . 8

Mixture 2

5 2 .9 ± 0 . 7

9 3.1 ± 0 . 4
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4.2.2

Lipid Hydroperoxide

The lipid hydroperoxide assay is an assessment of the formation of highly
reactive hydroperoxide of lipid from lipid peroxidation. As an index of oxidative
injury to cells from reactive compounds such as SMX-HA, the lipid hydroperoxide
assay was also employed to evaluate potentially protective effects of anti-oxidants
from natural herbs. To evaluate the effect of reactive drug metabolites and
anti-oxidants, Jurkat £6.1 cells were exposed to SMX-HA 400 pM for 2 h with or
without pretreatment for 30 minutes with BE, Cro, Res or Sal or mixture 1 and
mixture 2.
Jurkat £6.1 cells were incubated with 400 pM SMX-HA for 2 h showed
significant increased in lipid hydroperoxide formation (24.47 ± 3.59%) (Figure
10-A), which indicated that SMX-HA, the reactive electrophilic metabolite, cause
oxidative stress to the lipid. Previous experiment (LDH release assay) has shown
the chemoprotective effect of these four chemicals on the cellular membrane. To
further confirm their antioxidant activities on lipid peroxidation, Jurkat £6.1 cells
were incubated with 400 pM SMX-HA for 2 h with or without pretreatment with
the pure TCM constituents and two synthetic mixtures for 30 min. We choose the
concentrations of phytochemicals at 5 and 20 pM which are still in the safety
range we established from the LDH release assay (Table 3 and Table 4).
There was no increase in lipid hydroperoxide formation compared to
vehicle-treated control cells (Fig. 10-A) when Jurkat £6.1 cells were incubated
with 5 and 20 pM BE for 30 min. However, treatment of cells with 400 pM
SMX-HA induced the oxidation of lipid, resulting in the formation of 24.47 pM ±
3.59% (mean ± SEM, N=3) lipid hydroperoxide, which is significantly higher than
in vehicle treated control cells (P<0.01). Conversely, pretreatment with BE at both
5 and 20 pM for 30 min followed by incubation of the cells with SMX-HA 400
pM 2 h, partly attenuated SMX-HA induced oxidative stress to the lipid. BE

86

pretreatment for 30 min decreased the content of lipid hydroperoxide subsequent
to treatment with SMX-HA 400 pM for 2 h by 44.2% and 81.5% (P<0.05, vs
SMX-HA treated), at the lower and higher concentrations, respectively (Fig 10-A).
Although it was not significant at the 5 pM pretreatment, we can still see that the
attenuation effect of BE exhibit concentration-dependent manner.
In this experiment, other selected antioxidant chemicals all showed the
similar dose-response protective effect, indicating that the concentration range we
choose for measurement of lipid peroxidation is relevant.
When Jurkat £6.1 cells were incubated with Cro 5 pM for 30 min there
was a slight increase in lipid hydroperoxide content (Fig 10-B). However, neither
Res nor Sal caused detectable increase in lipid hydroperoxide (Fig 10C-D),
following preincubation for 30 min at concentrations of 5 or 20 pM and an
additional 2 h in the absence of SMX-HA (negative controls). Although 5 pM Cro
alone slightly increased lipid hydroperoxide concentration, together with Res and
Sal, pretreatment with these three latter compounds for 30 min all attenuated
SMX-HA induced lipid hydroperoxide formation. At the higher concentration
studied (20 pM), the attenuation of lipid hydroperoxide formation was 84%
(P<0.05), 93% (PO.01), 91% (P<0.05) for Cro (Fig 10-B), Res (Fig 10-C) and Sal
(Fig 10-D), respectively. These three compounds were also effective at 5 pM and
showed better chemoprotective effects than BE. The attenuation of lipid
hydroperoxide formation in SMX-HA treated cells was 72% (P<0.05) for Cro,
compared to 72%, 66% each for Res (P<0.05) and Sal. The attenuation of Sal at 5
pM was not statistically significant due to sample variability, although the
experimental data does suggest a trend (Fig 10-D).
In attenuation of LDH release caused by treatment with 400 pM SMX-HA,
the mixtures of pure TCM constituents worked as more effective chemoprotectants
than single compounds at equimolar concentrations. We further confirmed our
hypothesis that anti-oxidants selected for the study can work through
complementary mechanisms to produce a greater protective effect than single

components alone on an equimolar basis. Also, we compared the chemoprotective
effects of mixture 1 and mixture 2 to evaluate the antioxidant property of Sal.
30 min treatment with 5 pM mixture 1, mixture 2 slightly increased lipid
hydroperoxide content compared with vehicle control in Jurkat £6.1 cells (Fig 10
E-F). Nevertheless, these mixtures were comparable in their ability to attenuate
SMX-HA-mediated lipid peroxidation in Jurkat £6.1 cells. Lipid hydroperoxide
content was decreased by pretreatment with 5 or 20 pM Mixture 1 by 47% and
96% (PO.05), respectively (Fig 10-E) and by 5 or 20 pM Mixture 2 by 42% and
93%, respectively (Fig 10-F). Related to sample variability, only the attenuation of
mixture 1 at 20 pM was statistically significant but there was a trend for
concentration-dependent chemoprotection. The comparative ability of the various
treatments to attenuate SMX-HA cytotoxicity in Jurkat £6.1 cells is summarized in
Table 6. Among these four single constituent of TCM, Cro, Res, and Sal exhibit
better chemoprotective effects than was BE. Cro at 5 pM and Res at 20 pM
showed more powerful attenuation in SMX-HA mediated lipid peroxidation. When
overall comparison was done, we found that either mixture 1 or mixture 2 at higher
concentration both were more effective than a single chemical. Moreover, mixture
1 at 20 pM maximally attenuated SMX-HA induced lipid peroxidation. From this
result, we concluded that the better chemoprotective effects of mixtures were
achieved through synergistic effects of TCM constituents. Also the presence of Sal
appeared to enhance the antioxidant ability of the mixture.
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Figure 10. Effect of pretreatment of Jurkat £6.1 cells with baicalein,
crocetin, resveratrol, schisanhenol, mixture 1, and mixture 2 on the SMX-HA
mediated lipid peroxidation

A. Jurkat E6.1 cells were preincubated with 0, 5 or 20 pM BE for 30 min followed
by treatment for 2 h with 400 pM SMX-HA. Data are expressed as mean ±
standard error, N= 3 with experiments performed with three different samples of
cultured cells on different days. Significant differences in lipid hydroperoxide
content were determined by comparing SMX-HA 400 pM treated cells with all
other groups of cells. Levels of significance are designated by *P<0.05, **P<0.01
relative to SMX-HA 400 pM. In addition, the content of lipid hydroperoxide in
each group was compared to the vehicle control to identify treatments that differed.
Levels of significance are designated by #P<0.05, # #P<0.01.

B. Jurkat £6.1 cells were preincubated with 0, 5 or 20 pM Cro for 30 min
followed by treatment for 2 h with 400 pM SMX-HA. Data are expressed as mean
± standard error, N= 3 with experiments performed with three different samples of
cultured cells on different days. Significant differences in lipid hydroperoxide
content were determined by comparing SMX-HA 400 pM treated cells with all
other groups of cells. Levels of significance are designated by *P<0.05, **P<0.01
relative to SMX-HA 400 pM. In addition, the content of lipid hydroperoxide in
each group was compared to the vehicle control to identify treatments that differed.
Levels of significance are designated by #P<0.05, # #P<0.01.
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C. Jurkat E6.\ cells were preincubated with 0, 5 or 20 pM Res for 30 min
followed by treatment for 2 h with 400 pM SMX-HA. Data are expressed as mean
± standard error, N= 3 with experiments performed with three different samples of
cultured cells on different days. Significant differences in lipid hydroperoxide
content were determined by comparing SMX-HA 400 pM treated cells with all
other groups of cells. Levels of significance are designated by *P<0.05, **P<0.01
relative to SMX-HA 400 pM. In addition, the content of lipid hydroperoxide in
each group was compared to the vehicle control to identify treatments that differed.
Levels of significance are designated by #P<0.05, # #P<0.01.

D. Jurkat £'6.1 cells were preincubated with 0, 5 or 20 pM Sal for 30 min followed
by treatment for 2 h with 400 pM SMX-HA. Data are expressed as mean ±
standard error, N= 3 with experiments performed with three different samples of
cultured cells on different days. Significant differences in lipid hydroperoxide
content were determined by comparing SMX-HA 400 pM treated cells with all
other groups of cells. Levels of significance are designated by *P<0.05, **P<0.01
relative to SMX-HA 400 pM. In addition, the content of lipid hydroperoxide in
each group was compared to the vehicle control to identify treatments that differed.
Levels of significance are designated by #P<0.05, ##P<0.01.
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E. Jurkat £6.1 cells were preincubated with 0, 5 or 20 pM mixture 1 for 30 min
followed by treatment for 2 h with 400 pM SMX-HA. Data are expressed as mean
± standard error, N= 3 with experiments performed with three different samples of
cultured cells on different days. Significant differences in lipid hydroperoxide
content were determined by comparing SMX-HA 400 pM treated cells with all
other groups of cells. Levels of significance are designated by *P<0.05, **P<0.01
relative to SMX-HA 400 pM. In addition, the content of lipid hydroperoxide in
each group was compared to the vehicle control to identify treatments that differed.
Levels of significance are designated by #P<0.05, # #P<0.01.

F. Jurkat £6.1 cells were preincubated with 0, 5 or 20 pM mixture 2 for 30 min
followed by treatment for 2 h with 400 pM SMX-HA. Data are expressed as mean
± standard error, N= 3 with experiments performed with three different samples of
cultured cells on different days. Significant differences in lipid hydroperoxide
content were determined by comparing SMX-HA 400 pM treated cells with all
other groups of cells. Levels of significance are designated by *P<0.05, **P<0.01
relative to SMX-HA 400 pM. In addition, the content of lipid hydroperoxide in
each group was compared to the vehicle control to identify treatments that differed.
Levels of significance are designated by #P<0.05, # #P<0.01.
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Table 6. Attenuation of the Formation of Lipid Hydroperoxide from Jurkat
E 6 .1
Cells Following Treatment with 400 pM Sulphamethoxazole
N-hydroxylamine (SMX-HA) for 2 h
Cells were pretreated with 5 or 20 pM of each of the TCM constituents and
Mixtures 1 and 2 for 30 min prior to a 2 h incubation with 400pM SMX-HA.
Differences between the amounts of Lipid Hydroperoxide were determined by
Student’s t-test within each TCM concentration range as a comparison of efficacy
of the various treatments (*P<0.05, vs mixture 1).
Mixture 1 is an equimolar mixture of Baicalein, Crocetin and Resveratrol and
Schisanhenol; Mixture 2 is an equimolar mixture of Baicalein, Crocetin, and
Resveratrol
A t t e n u a t io n o f L ip id H y d r o p e r o x id e
fo r m a tio n c a u s e d b y t r e a t m e n t w it h 400 pM SM X-

H A for 2 h
(% decrease; m ean ± SE M , N =3)
C om pound

5 pM

20 pM

B a ic a le in

44.2 ± 3 .6

81.5 ± 2 .1

C r o c e t in

72.1 ± 1 .7 *

83.8 ± 1 .6

R esv e ra tro l

71.8 ± 3 . 7 *

92.5 ± 3 .1

S c h is a n h e n o l

65.8 ± 4 .7

91.1 ± 3 .4

M ix tu r e 1

47.0 ± 1 .0

95.6 ± 5 .1

M ix tu r e 2

41.6 ± 1 .1

93.4 ± 5 .9

95

4.2.3

Protein Carbonyl Content
The protein carbonyl content in Jurkat £6.1 cells was also conducted as a

complementary assay for oxidative and nitrosative stress. Protein carbonyl assay
was also used to evaluate the antioxidative effect of pure constituents of traditional
Chinese remedies on oxidative stress-induced protein oxidation. In this experiment,
the protein carbonyl content was expressed as percent of control.
Incubation of Jurkat £6.1 cells to 400 pM SMX-HA for 2 h about 245%
protein carbonyl was formed in Jurkat £6.1 cells (Fig 11-A). This cytotoxicity
effect is probably due to the combined effect of this reactive electrophilic
metabolite and associated oxidative stress. To evaluate the chemoprotection of the
selected phytochemicals on protein oxidation, Jurkat £6.1 cells were exposed to
SMX-HA (400 pM) for 2 h with or without pretreatment with the pure TCM
constituents and two synthetic mixtures for 30 min. The concentrations of the
phytochemicals tested were same as in the lipid hydroperoxide assay.
Jurkat £6.1 cells were exposed to 5 or 20 pM of BE for 30 min, there was
no increase of protein carbonyl formation from Jurkat £6.1 cells compared to
vehicle-treated control cells (Fig 11-A). In contrast, SMX-HA 400 pM oxidized
protein to form a significant concentration of protein carbonyl 245% ± 28% (mean
± SEM, N=3) which is significantly higher than in vehicle treated control cells
(P<0.05). On the other hand, BE at both 5 and 20 pM, partially protected Jurkat
cells from SMX-HA-mediated protein oxidation. Pretreatment with both lower and
higher concentrations of BE effectively decreased SMX-HA induced protein
carbonylation. Protein carbonyl content was decreased by pretreatment with 5 or
20 pM BE by 46% (P<0.05) and 74% (P<0.01), respectively (Fig 11-A).
Similar to BE, we did not find significant increase in protein carbonyl
content compared with vehicle control when Jurkat £6.1 cells were incubated with
Cro and Sal at 5 and 20 pM for 30 min (Fig 11-B 11-D). While, following
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treatment with Res at 5 pM slightly increased protein carbonyl content (Fig 11-C)
probably due to the sample variability. When each attenuation effect of these four
constituents of TCM was analysis, BE, Cro, and Sal were apparently better
chemoprotectants for SMX-HA-mediated protein oxidation than Res, for the
attenuation of protein carbonyl formation at the higher concentration studied (20
pM) was 74% (PO.Ol), 72% (PO.Ol), and 71% (PO.Ol) for BE (Fig. 11-A), Cro
(Fig. 11-B) and Sal (Fig. 11-D), respectively compared to 63% for Res (Fig. 11-C).
At a lower concentration (5 pM), BE, Cro, Sal were also more effective
than was Res. BE seemed to be slightly more effective than either Cro or Sal,
which were equipotent at both concentrations but the difference is not significant
(Table 6). At the lower dose (5 pM), the attenuation of protein carbonylation in
SMX-HA treated cells was 55% (PO.Ol) for Cro, compared to 6%, 46% (PO.05)
each for Res and Sal.
The same strategy was used to test the antioxidant effect of two synthetic
mixtures of TCM on the protein level. Treatment with 5 and 20 pM Mixture 1 or
Mixture 2 for 30 min plus 2 h did not increase protein carbonyl content compared
with vehicle control in Jurkat £6.1 cells. Moreover, these mixtures were
comparable in their ability to attenuate SMX-HA-mediated protein oxidation in
Jurkat £6.1 cells. Thus, the content of protein carbonyl was decreased by
pretreatment with 5 or 20 pM Mixture 1 by 75% (PO.Ol) and 82% (PO.Ol),
respectively (Fig 1IE) and by 5 or 20 pM Mixture 2 by 67% (PO.05) and 59%
(PO.05), respectively (Fig 11-F). The comparative ability of the various
treatments to attenuate SMX-HA induced protein oxidation in Jurkat £6.1 cells is
summarized in Table 7.
When

we

compared the

attenuation

effect

single

constituent,

the

chemoprotective effects of BE, Cro, and Sal are quite close either in 5 or 20 pM.
However, Res in this case exhibit the weakest cytoprotective effect, especially at
lower concentration. In addition, pretreatment with mixture 1 maximally decreased
SMX-HA induced protein carbonylation either at lower or higher doses. Again,

97

our hypothesis was proved in this experiment, which indicated that Sal plays a
vital role in the combination of pure TCM constituents and they work through
complementary mechanisms make the mixture to possess greater protective effect
than single component on an equimolar basis.
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Figure 11. Effect of pretreatment of Jurkat £6.1 cells with baicalein,
crocetin, resveratrol, schisanhenol, mixture 1, and mixture 2 on the SMX-HA
mediated protein carbonylation

A. Jurkat £6.1 cells were preincubated with 0, 5 or 20 pM BE for 30 min followed
by treatment for 2 h with 400 pM SMX-HA. Data are expressed as mean ±
standard error, N= 3 with experiments performed with three different samples of
cultured cells on different days. Significant differences in protein carbonyl content
were determined by comparing SMX-HA 400 pM treated cells with all other
groups of cells. Levels of significance are designated by *P<0.05, **P<0.01
relative to SMX-HA 400 pM. In addition, the content of protein carbonyl in each
group was compared to the vehicle control to identify treatments that differed.
Levels of significance are designated by #P<0.05.

B. Jurkat £6.1 cells were preincubated with 0, 5 or 20 pM Cro for 30 min
followed by treatment for 2 h with 400 pM SMX-HA. Data are expressed as mean
± standard error, N= 3 with experiments performed with three different samples of
cultured cells on different days. Significant differences in protein carbonyl content
were determined by comparing SMX-HA 400 pM treated cells with all other
groups of cells. Levels of significance are designated by *P<0.05, **P<0.01
relative to SMX-HA 400 pM. In addition, the content of protein carbonyl in each
group was compared to the vehicle control to identify treatments that differed.
Levels of significance are designated by #P<0.05.
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C. Jurkat £6.1 cells were preincubated with 0, 5 or 20 pM Res for 30 min
followed by treatment for 2 h with 400 pM SMX-HA. Data are expressed as mean
± standard error, N= 3 with experiments performed with three different samples of
cultured cells on different days. Significant differences in protein carbonyl content
were determined by comparing SMX-HA 400 pM treated cells with all other
groups of cells. Levels of significance are designated by *P<0.05, **P<0.01
relative to SMX-HA 400 pM. In addition, the content of protein carbonyl in each
group was compared to the vehicle control to identify treatments that differed.
Levels of significance are designated by #P<0.05, # #P<0.01.

D. Jurkat £6.1 cells were preincubated with 0, 5 or 20 pM Sal for 30 min followed
by treatment for 2 h with 400 pM SMX-HA. Data are expressed as mean ±
standard error, N= 3 with experiments performed with three different samples of
cultured cells on different days. Significant differences in protein carbonyl content
were determined by comparing SMX-HA 400 pM treated cells with all other
groups of cells. Levels of significance are designated by *P<0.05, **P<0.01
relative to SMX-HA 400 pM. In addition, the content of protein carbonyl in each
group was compared to the vehicle control to identify treatments that differed.
Levels of significance are designated by #P<0.05.
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E. Jurkat £6.1 cells were preincubated with 0, 5 or 20 pM mixture 1 for 30 min
followed by treatment for 2 h with 400 pM SMX-HA. Data are expressed as mean
± standard error, N= 3 with experiments performed with three different samples of
cultured cells on different days. Significant differences in protein carbonyl content
were determined by comparing SMX-HA 400 pM treated cells with all other
groups of cells. Levels of significance are designated by *P<0.05, **P<0.01
relative to SMX-HA 400 pM. In addition, the content of protein carbonyl in each
group was compared to the vehicle control to identify treatments that differed.
Levels of significance are designated by #P<0.05.

F. Jurkat £6.1 cells were preincubated with 0, 5 or 20 pM mixture 2 for 30 min
followed by treatment for 2 h with 400 pM SMX-HA. Data are expressed as mean
± standard error, N= 3 with experiments performed with three different samples of
cultured cells on different days. Significant differences in protein carbonyl content
were determined by comparing SMX-HA 400 pM treated cells with all other
groups of cells. Levels of significance are designated by *P<0.05, **P<0.01
relative to SMX-HA 400 pM. In addition, the content of protein carbonyl in each
group was compared to the vehicle control to identify treatments that differed.
Levels of significance are designated by #P<0.05.
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Table 7. Attenuation of the Protein Carbonylation from Jurkat E 6 .1 Cells
Following Treatment with 400p.M Sulphamethoxazole N-hydroxylamine
(SMX-HA) for 2 h
Cells were pretreated with 5 or 20 pM of each of the TCM constituents and
Mixtures 1 and 2 for 30 min prior to a 2 h incubation with 400pM SMX-HA.
Differences between the amounts of Protein Carbonyl were determined by
Student’s t-test within each TCM concentration range as a comparison of efficacy
of the various treatments (*P<0.05, vs mixture 1).
Mixture 1 is an equimolar mixture of Baicalein, Crocetin and Resveratrol and
Schisanhenol; Mixture 2 is an equimolar mixture of Baicalein, Crocetin, and
Resveratrol
A tte n u a tio n o f P r o te in C a r b o n y la tio n ca u se d
b y t r e a t m e n t w i t h 4 0 0 p M S M X -H A fo r 2 h

(% d e c re a s e ; m e a n ±
C om pound
B a ic a le in

5 juM

4 5 .7 ± 5 . 5 *

SE M , N =3)
20 pM

7 3 .6 ± 1 . 8

C r o c e tin

5 5 .0 ± 4 . 3

7 1 .8 ± 1 . 9

R esv e ra tro l

6.1 ± 1 . 4 *

6 2 .6 ± 8 . 6

S c h is a n h e n o l

4 5 .8 ± 5 . 3 *

7 1 .3 ± 1 . 9

M ix tu r e 1

7 4 .5 ± 3 . 8

8 1 .8 ± 3 . 9

M ix tu r e 2

6 6 .8 ± 5 . 2

5 9 .2 ± 6 . 5
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4.2.4

Disulfide Bonded Proteins
As a direct indication of oxidation, incubation of Jurkat £6.1 cells with 400

pM SMX-HA for 2 h (Fig 12-C) caused the virtual disappearance of the
peroxiredoxin (Prx) band comprised of the 2-Cys dimeric disulphides of
peroxiredoxins 1 and 2 (Prx 1 and 2; designated spot 1) compared to vehicle treated
control cells (Fig 12-A) on R2D-PAGE gels. Prx 1-4 are dimeric proteins in which
each monomer contains an active cysteine thiol residue. The disappearance of these
protein is due to the oxidative effect of SMX-HA, which converts Prx 1 or 2 to its
over oxidized sulfinic acid form. DTT is unable to reduce protein sulfinic acids so
the over oxidized Prxs run on the diagonal line, causing the disappearance of Prx 1
and 2 from the right side and below the diagonal line of the reduced 2D-gel.
As a further sign of oxidative and/or nitrosative stress, SMX-HA-treated
Jurkat £6.1 cells (Fig, 12-C) exhibit more protein spots derived from reduction of
heterodimeric or homodimeric protein disulphides than the vehicle-treated control
cells (Fig 12-A) or in Jurkat cells treated only with 5 pM BE (Fig. 12-B). These
protein spots that occurred only after treatment with SMX-HA were labeled with
letters (from a to 1). The apparent molecular weights of these proteins are
approximately 30, 35, 37, 39, 60, 65, 90, 112, 114, 115, 116, and 130 kDa,
respectively. Most of these spots originated from proteins with intermolecular
disulphide bonds and appeared below and to the right side of the diagonal line.
To evaluate the chemoprotective effects of the selected phytochemicals on the
oxidation of reactive cysteine thiol containing proteins to protein mixed disulphides,
Jurkat £6.1 cells were exposed to SMX-HA (400 pM) for 2 h with or without
pretreatment with the pure TCM constituents and two synthetic mixtures for 30 min.
The concentrations of the phytochemicals tested were in the range where there was
no enhanced release of LDH relative to control cells, even 24 h after initial exposure
to the TCM constituents (Tables 3 and 4). In other words, these concentrations
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tested for chemoprotection did not cause even mild cytotoxicity to the cells.
Treatment of Jurkat £'6.1 cells with 1 pM (Fig. 12-D) or 5 pM BE (Fig. 12-E)
showed a concentration-dependent attenuation of the oxidation of Prx 1 and 2 best
described as minor. However, pretreatment of Jurkat cells with 5 pM BE for 30 min
caused the apparent loss of protein spots b, c, e, h and k, suggesting the oxidation of
these proteins to intermolecular disulphide bonds was attenuated by pretreatment
with 5 pM BE. Pretreatment with 1 pM BE did not attenuate the oxidation of Prxs 1
and 2 but it did attenuate the SMX-HA-mediated disappearance of proteins b, c, h,
and k, verifying its antioxidant activity.
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Figure 12.

Protective effects of Baicalein (BE: 1 and 5pM) on 400 pM

SMX-HA-induced intercellular oxidation in Jurkat £6.1 cells evaluated by
R2D-PAGE with silver staining.
A = vehicle control (0.2% DMSO); B = 5 (iM BE; C = 400 pM SMX-HA; D = 1
pM BE + 400 pM SMX-HA; E = 5 pM BE + 400 pM SMX-HA,

The protein spots seen in the vehicle-treated control cells are identified by numbers
while the novel proteins found when the Jurkat £6.1 cells were incubated with
SMX-HA are identified by letters. Supernatant proteins (85 pg) were loaded to the
phase 1 gel in each case. All gels were run in triplicate, and the experiment was
repeated three times, with a different batch of cells each time. A single
representative gel is shown for each of the treatment conditions. The data from all
2D-dels for each experimental condition are summarized in tables 8 and 9.

108

Non-Reducing

7*

CD

CL

C

o
CJQ

Non-Reducing
◄--------------------------------------------------------------------------------------

Reducing

109

The second set of R2D-PAGE data shown (Figs. 13A-F) is for Cro. In all
experiments, treatment of Jurkat £6.1 cells with 400 pM SMX-HA caused the
complete loss of the Prx spot (Fig. 13-C). In contrast to the BE data, there was
some detectable attenuation of Prxs 1 and 2 by the 1 pM Cro pretreatment (Figs.
13-D,E) that was slightly more pronounced at 5 pM Cro (Fig. 13-F). Although this
protection is still only partial, there was concentration-dependent chemoprotection
on SMX-HA-mediated oxidation of Prx according to the relative intensities of the
Prx 1 and 2 spot. Besides, pretreatment with 5 pM Cro protected against
SMX-HA-mediated loss of proteins b, c, h, i, j, k whereas pretreatment with 1 pM
Cro lead to the loss of proteins b, c, i, 1. In other words, the higher concentration of
Cro protected against the oxidation of three proteins (h,j,k), an effect not observed
with 1 pM Cro.
Because Cro was a more potent chemoprotectant for Prx 1 and 2, we also
evaluated its effect by loading twice as much protein to the first dimension gel (Fig.
13-D). The interpretation of the protective effect, based on Prx 1 and 2 was not
different at the t20 different protein concentrations. Consequently, gels were run at
the higher protein concentrations for only the most effective chemoprotectans,
based on the R2D gel analysis (Cro, and Mixtures 1 and 2).
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Figure 13.

Protective effects of Crocetin (Cro; 1 and 5pM) on 400 pM

SMX-HA-induced intercellular oxidation in Jurkat £6.1 cells evaluated by
R2D-PAGE with silver staining.
A = vehicle control (0.2% DMSO); B = 5 pM Cro; C = 400 pM SMX-HA; D = 1
pM Cro + 400 pM SMX-HA (170 pg protein); E = 1 pM Cro + 400 pM SMX-HA
(85 pg protein); F = 5 pM Cro + 400 pM SMX-HA,

The protein spots seen in the vehicle-treated control cells are identified by numbers
while the novel proteins found when the Jurkat £6.1 cells were incubated with
SMX-HA are identified by letters. Supernatant proteins (85 pg) were loaded to the
phase 1 gel in each case. All gels were run in triplicate, and the experiment was
repeated three times, with a different batch of cells each time. A single
representative gel is shown for each of the treatment conditions. The data from all
2D-dels for each experimental condition are summarized in tables 8 and 9..
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The third set of data presented (Fig. 14A-E) is for Res. Pretreatment with 5
pM (Fig 14-E) but not 1 pM Res (Fig. 14-D) partially prevented oxidation of Prx 1
and 2 and also prevented the oxidation of proteins b, c, h, i, j and k, which
disappeared from the gel, clearly demonstrating the concentration-response of the
Res effect. However, pretreatment with 1 pM Res for 30 min prior to SMX-HA
prevented the oxidation of protein spots b, i, j k. Of interest, 5 pM Res (Fig. 14-B)
appeared to increase the intensity of the Prx 1 and 2 spot, suggesting it attenuated
the formation of Prx 1/2 sulfinic acids in Jurkat £6.1, normal incubation conditions
for 2 h, in the absence of SMX-HA.

Figure 14.

Protective effects of Resveratrol (Res; 1 and 5 pM) on 400 pM

SMX-HA-induced intercellular oxidation in Jurkat £"6.1 cells evaluated by
R2D-PAGE with silver staining

A = vehicle control (0.2% DMSO); B = 5 pM Res; C = 400 pM SMX-HA; D = 1
HiM Res + 400 pM SMX-HA; E = 5 pM Res + 400 pM SMX-HA

The protein spots seen in the vehicle-treated control cells are identified by numbers
while the novel proteins found when the Jurkat £6.1 cells were incubated with
SMX-HA are identified by letters. Supernatant proteins (85 pg) were loaded to the
phase 1 gel in each case. All gels were run in triplicate, and the experiment was
repeated three times, with a different batch of cells each time. A single
representative gel is shown for each of the treatment conditions. The data from all
2D-dels for each experimental condition are summarized in tables 8 and 9.
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The final set of single compound data presented (Figs. 15A-E) is for Sal.
Similar to the previous results described for BE and Res, treatment of Jurkat £6.1
cells with 1 pM Sal (Fig. 15-D) did not attenuate the oxidation of Prx 1/2, an effect
observed with the higher concentration of Sal. Pretreatment for 30 min with 5 pM
Sal partially attenuated SMX-HA-mediated oxidation of Prx 1/2 in Jurkat E6.1
cells and also protected against disulphide formation of proteins b, c, d, h, i, j and 1
(Fig, 15-E). Pretreatment of Jurkat cells with the lower concentration of Sal (1 pM;
Fig 15-D) did prevent the oxidative conversion of proteins b, d, j, k and 1to their
homomeric or heterodimeric disulphides.
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Figure 15. Protective effects of Schishenol (Sal; 1 and 5 pM) on 400 pM
SMX-HA-induced intracellular oxidation in Jurkat E 6 .1 cells evaluated by
R2D-PAGE with silver staining
A = vehicle control (0.2% DMSO); B = 5 pM Sal; C = 400 pM SMX-HA; D = 1
pM Sal + 400 pM SMX-HA; E = 5 pM Sal + 400 pM SMX-HA,

The protein spots seen in the vehicle-treated control cells are identified by numbers
while the novel proteins found when the Jurkat £6.1 cells were incubated with
SMX-HA are identified by letters. Supernatant proteins (85 pg) were loaded to the
phase 1 gel in each case. All gels were run in triplicate, and the experiment was
repeated three times, with a different batch of cells each time. A single
representative gel is shown for each of the treatment conditions. The data from all
2D-dels for each experimental condition are summarized in tables 8 and 9.
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In experiments described earlier in the Results, we compared the
chemoprotectant effects of two synthetic mixtures with single antioxidant
constituents of TCM. Mixture 1, in particular, was effective in attenuating
SMX-HA-mediated LDH release, lipid hydroperoxide formation and protein
carbonyl formation, the endpoints used to evaluate cytotoxicity. Here R2D PAGE
analysis was used in an attempt to differentiate the relative antioxidant activities of
the mixtures in comparison to the four individual the most reliable TCM
constituents, at equimolar concentrations. Overall, in all R2D-PAGE experiments
performed, attenuation of the disappearance of Prx 1/2 was the most sensitive
indicator for antioxidant activity in cells treated with SMX-HA.
The mixture 1 (BE:Cro:Res:Sal; 1:1:1:1) data are shown below (Figs. 16A-F).
Both 1 and 5 pM mixture 1 attenuated the oxidation of Prx 1/2 in Jurkat £6.1 cells
resulting from treatment with 400 pM SMX-HA (Fig. 16-C) in a concentration
dependent-manner. Although this protective effect was only partial, it is somewhat
reassuring that the attenuation at the 1 pM concentration occurred in all gels
loaded with rather 85 (Fig. 16-E) or 170 pg protein (Fig. 16-D). Moreover, the
density of spot 1 (Prx 1/2) served as an effective dosimeter of the concentrationdependent antioxidant effects of mixture 1. Thus, the intensity of spot 1 increased
from Fig. 16-E (1 pM mix 1; 85 pg protein) to Fig. 16-D (1 pM mix 1; 170 pg
protein) to Fig. 16-F (5 pM mix 1; 85 pg protein). In addition, pretreatment with 5
pM mixture 1 (Fig. 16-F) attenuated the oxidation of proteins a, b, c, d, e, i, k
compared to pretreatment with 1 pM mixture 1 (Fig. 16-E) which prevented the
oxidation of proteins b, c, d, e, 1.
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Figure 16.

Protective effects of synthetic mixture 1 (mix 1; 1 and 5 gM) on

400 gM SMX-HA-induced intracellular oxidation in Jurkat 2?6.1 cells
evaluated using R2D-PAGE followed by silver staining
A = vehicle control (0.2% DMSO); B = 5 gM mix 1; C = 400 gM SMX-HA; D = 1
gM mix 1 + 400 gM SMX-HA (170 gg protein); E = 1 gM mix 1 + 400 gM
SMX-HA (85 gg protein); F = 5 gM mix 1 + 400 gM SMX-HA (85 gg protein),

Mixture 1 is an equimolar ratio of baicalein, crocetin, resveratrol and schishenol.

The protein spots seen in the vehicle-treated control cells are identified by numbers
while the novel proteins found when the Jurkat E6.1 cells were incubated with
SMX-HA are identified by letters. Supernatant proteins (85 gg) were loaded to the
phase 1 gel in each case. All gels were run in triplicate, and the experiment was
repeated three times, with a different batch of cells each time. A single
representative gel is shown for each of the treatment conditions. The data from all
2D-dels for each experimental condition are summarized in tables 8 and 9.
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Finally, we tested the ability of synthetic mixture 2 (BE:Cro:Res; 1:1:1; Fig.
17-D, -E and -F) to attenuate the SMX-HA induced oxidative changes in Jurkat
£6.1 cells (Fig. 17C). Based on the intensity of the Prx 1/2 spot, this mixture was
more effective than any of the single antioxidants tested or mixture 1, at equivalent
concentrations. Pretreatment with either 1 or 5 pM mixture 2 prevented the
oxidation of proteins a, b, c, d, k, 1 (Fig. 17-E) and a, b, c, h, i, k, 1 (Fig. 17-F),
respectively. The results of the changes in the disulphide proteome , attenuated
(Fig. 17 D-F) partly reduced SMX-HA mediated disulphide proteome, which
represent in the disappearance of protein spots a, b, c, h, i, k, 1 and respectively.
The comparative changes in the disulphide proteome of all treatments are
summarized in Table 8 and 9.
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Figure 17. Protective effects of synthetic mixture 2 (mix 2; 1 and 5 pM) on 400
pM SMX-HA-induced intracellular oxidation in Jurkatis6.1 cells evaluated
using R2D-PAGE followed by silver staining

A = vehicle control (0.2% DMSO); B = 5 pM mix 2; C = 400 pM SMX-HA; D =
1 pM mix 2 + 400 pM SMX-HA (170 fig protein); E = 1 pM mix 2 + 400 pM
SMX-HA (85 pg protein); F = 5 pM mix 2 + 400 pM SMX-HA (85 pg protein)

Mixture 2 is an equimolar ratio of baicalein, crocetin, and resveratrol

The protein spots seen in the vehicle-treated control cells are identified by numbers
while the novel proteins found when the Jurkat £6.1 cells were incubated with
SMX-HA are identified by letters. Mitochondrial supernatant proteins (85 pg)
were loaded to the phase 1 gel in each case. All gels were run in triplicate, and the
experiment was repeated three times, with a different batch of cells each time. A
single representative gel is shown for each of the treatment conditions. The data
from all 2D-dels for each experimental condition are summarized in tables 8 and 9.
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Treatment of Jurkat £6.1 cells with 5 pM BE, Cro, Res, Sal, mixture 1 or
mixture 2 alone had no or little effect on the disulphide proteome in each case. The
protein spots that are identified on the R2D gels and these data for each of the
treatments with the phytochemical alone are summarized in Table 8. The numbers
in this table indicate the number of times each spot was observed in the three
different gels run for each individual treatment. Each number represents an
individual treatment of a different batch of Jurkat £6.1 cells.
Of importance for our study, the effect of the phytochemicals on the intensity
of the Prx spot(s) was small compared to that from untreated control cells. Other
changes in the disulfide pattern were summarized in Table 9. In this table, there
were several new protein spots that were labeled with letters. These proteins
underwent oxidation process and formed inter- or in intra-molecular disulphide
bonds under oxidative effect of SMX-HA. Among these proteins, some of them
have been previously identified by mass spectrometric analysis of tryptic digests in a
related study which evaluated the formation of protein-glutathione mixed
disulphides by S-glutathionylation of proteins in Jurkat cells following treatment
with cellular oxidants. Earlier unpublished work in our laboratory also identified
HSP 70-pB; aldolase; HSP 60 and enolase using both matrix associated laser
desorption/ionisation-time of flight-mass spectrometry (MALDI-TOF-MS) and/or
electrospray

ionisation-quadropole-time of flight-tandem mass spectrometry

(ESQ-Q-TOF-MS/MS) analysis of proteins that formed covalent bonds when
MOLT-3 cells were treated with SMX-HA, a reaction that occurs primarily at the
thiolate ion of proteins with reactive cysteine residues .When we compared the
attenuation effect of 5 pM single constituent on SMX-HA induced disulfide
proteome, there was no significant difference shown either in the intensity of Prx or
the numbers of disulfide proteome formation mediated by SMX-HA. However, in
low concentration’s (1 pM) comparison, mixtures showed better antioxidant effects
than the single chemical. More specifically, when we compared the intensity of Prx,
pretreatment with mixture 1 was associated with higher intensity of Prx than

125

pretreatment with mixture 2, suggesting that mixture 1 possess the most potent
antioxidant effect in regulating the redox states of disulfide proteome. This
conclusion was correlated to the previous results, suggesting that the combination of
pure TCM constituents can work through complementary mechanisms to produce a
greater protective effect than single component on an equimolar basis; also, the
enhanced chemoprotective effect of mixture 1 is partly credited to the presence of
Sal, as noted above an important contributor of the mixture.
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Table 8. Proteins formed from protein-protein disulphides that occurred on
R2D gels of Jurkat £"6.1 cells treated with 5 pM Baicalein, Crocetin,
Resveratrol, Schisanhenol or Mixture 1 or 2, compared to vehicle-treated
control cells
Cells were incubated with 5 pM of each of the TCM constituents or Mixtures 1 or
2 for 30 min. Grey squares indicate the presence of the corresponding protein spots
in Jurkat E6.1 cells under the different treatment conditions. The numbers in each
square indicate the number of times these protein spots showed up in three
independent experiments.
Mixture 1 is an equimolar mixture of baicalein, crocetin and resveratrol and
schisanhenol; Mixture 2 is an equimolar mixture of baicalein, crocetin, and
resveratrol.
The monomeric molecular weights of proteins 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 are 25,
64, 73, 82, 74, 75, 85, 58, 50, 55 kDa, respectively
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Table 9. Proteins formed from protein-protein disulphides that occurred on
R2D gels of Jurkat E 6 .1 cells pretreated with 5 pM Baicalein, Crocetin,
Resveratrol, Schisanhenol or Mixture 1 or 2 for 30 min prior to incubation
with 400 pM SMX-HA for 2 h
Cells were pretreated by incubation with 1 and 5 pM of each of the TCM
constituents or Mixtures 1 or 2 for 30 min prior to exposure to 400 pM SMX-HA
for 2 h. Grey squares indicate the presence of the corresponding protein spots in
Jurkat E6.1 cells under the different treatment conditions. The numbers in each
square indicate the number of times these protein spots showed up in three
independent experiments.
Mixture 1 is an equimolar mixture of baicalein, crocetin and resveratrol and
schisanhenol; Mixture 2 is an equimolar mixture of baicalein, crocetin, and
resveratrol.
The monomeric molecular weights of proteins 1-10 are shown in Table 8. The
monomeric weights of proteins a-1 are: 30, 35, 37, 39, 60, 65, 90, 112, 114, 115,
116 and 130 kDa, respectively.
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CHAPTER 5:

DISCUSSION

The goal of our research was to pursue the hypothesis that anti-oxidant
compounds of herbal origin, such as BE, Cro, Res and Sal, may mediate
sulfamethoxazole hydroxylamine (SMX-HA) induced oxidative and nitrosative
stress in Jurkat £6.1 cells. The compounds tested in our study have been used,
along with other herbal medicines, for over two thousands years as part of
Traditional Chinese Medicine.
SMX is a antimicrobial drug that has been used to treat a number of common
and important infections. However, a major problem associated with sulphonamide
therapy has been hypersensitivity reactions. The pathogenesis of hypersensitivity
reactions to sulphonamides is complex and has been incompletely understood, but
appears to involve initial bioactivation of the sulphonamide to a reactive
intermediate followed by cellular injury and a misdirected immune response. Carr
et al. have demonstrated that, in the context of HIV infection - known to be a risk
factor for a sharp increase in risk for sulphonamide hypersensitivity - the
pathogenesis of SMX-HA induced hypersensitivity ADRs, at least in vitro,
appeared to be associated with decreased total GSH concentrations (Carr, Tindall
et al. 1993) while in the same context it has been suggested that there are increases
in activated form of caspase-3 (Adeyanju, Krizova et al. 2009). The role of
oxidative stress in serious ADRs has been increasingly appreciated. With special
relevance to serious ADRs, it has been reported that arylhydroxylamine
metabolites of SMX induce ROS generation in normal human epidermal
keratinocytes (Vyas, Roychowdhury et al. 2005). During the auto-oxidation
process of SMX-HA, a succession of reactions occurs, which include reduction of
molecular oxygen to superoxide, followed by conversion of superoxide to
hydrogen peroxide either spontaneously or catalyzed by superoxide dismutase
(SOD). H2O2 can be converted to the hydroxyl radical through a Fenton reaction
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(Vyas, Roychowdhury et al. 2005). Additionally, superoxide rapidly reacts with
nitric oxide which is often produced simultaneously in cells, to form peroxynitrite.
In this series of reactions, the production of superoxide, hydrogen peroxide,
hydroxide radicals, and peroxynitrite all produce oxidative and nitrosative stress.
These alterations in ROS and RNS may form the biochemical basis for cellular
injury leading to a misdirected immune response in sulphonamide hypersensitivity.
ROS and RNS generated during the metabolic process can cause cell death and
oxidation of protein and lipid, which we evaluated as increases of protein carbonyl
content and lipid hydroperoxide.
We believe that attenuating oxidative stress will reduce cellular injury and
damage, and may reverse or prevent drug hypersensitivity in patients at risk. Our
hypothesis was that BE, Cro, Res, and Sal purified anti-oxidants, common
constituents of TCM, would attenuate oxidative and nitrosative stress and maintain
the redox states of cells. The first objective of our study was to determine the
individual effect of BE, Cro, Res, and Sal for cell viability in Jurkat £6.1 cells, in a
time- and concentration-dependent manner. The ability of these compounds to
alter oxidative injury in these low concentrations has not been reported previously.
These observations are potentially important and suggest non-toxic concentrations
of herbal phytochemicals can serve as chemoprotectants. Moreover, our results
suggested a possible duality between the pro-oxidant and anti-oxidant effects of
BE, Cro, Res, and Sal. Many of the desired pharmacological and biochemical
activities of natural products are believed to be related to their anti-oxidant effects.
However, it is known that anti-oxidants can also act as reducing agents. They can
thus exhibit protective effect at low concentration while act as pro-oxidants and
show their potential toxic, pro-oxidative effect at higher concentrations (Woo,
Cheng et al. 2005). Many studies focused on herbal medicines in isolation have
ignored the potential pro-oxidative effects of these compounds at higher
concentrations.
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The antioxidant basis of BE has been illustrated by Woo and colleagues who
applied BE on rat cardiomyocytes, and found that BE performed its anti-oxidant
activities by forming stable semiquinone radicals (Woo, Cheng et al. 2005). The
oxidation of flavonoids to form semiquinone radicals was accompanied with the
generation of O2 •, which can further oxidize the flavonoids, leading to the
production of H2O2 (Woo, Cheng et al. 2005). The generation of ROS in this process
may be the basis for the pro-oxidant effect of BE. Although this issue has not been
investigated with Cro, the anti-oxidant and prooxidant activity of carotenoids has
been reported due to be related to various factors including the structure, the location
of carotenoid molecule in the cell, the interaction with other anti-oxidants, the partial
pressure of oxygen, as well as its cellular concentrations (Young and Lowe 2001).
High concentrations of carotenoids may increase the permeability of biological
membrane (Lowe, Vlismas et al. 2003) and permit free radicals to enter cells easily.
It has also been reported that high concentrations (10 pM) of P-carotene can enhance
the pro-oxidant (Fotiou, Fotiou et al.) effect by inducing catalase and superoxide
dismutase as well as depleting the amount of glutathione peroxidase (Lawlor and
O'Brien 1995). In addition, the formation of a carotenoid peroxyl radical during the
interaction with ROS can further induce lipoperoxidation (carotenoids as
prooxidants 2003). Resveratrol has also been reported to possess pro-oxidant
activities which may be part of the basis of its reported anti-proliferative,
pro-apoptotic, and anticancer properties (Ruweler, Gulden et al. 2009). Moreover,
Fotiou et al. found that resveratrol can cause neurotoxicity through up-regulation of
nitric oxide synthase and inducing peroxynitrite and singlet oxygen formation
(Fotiou, Fotiou et al. 2010). The prooxidant activity of schisanhenol has not been
well characterized in the literature. However, the previous work that have been done
in our lab showed that 100 pM of schisanhenol caused a significant increase in LDH
release from HEK 293 cells when compared to the DMSO control, indicating
toxicity to the cells at this concentration.
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Our second objective was to determine the effect of pure constituents of
traditional Chinese remedies on cell viability in cells treated with SMX-HA. Most
current assays for measuring cytotoxicity are based on alterations in plasma
membrane permeability and the subsequent release (leakage) of components into
the supernatant, or the uptake of dyes, which are normally excluded by viable cells.
This study using the LDH release assay demonstrated an attenuation of SMX-HA
cytotoxicity by BE, Cro, Res, and Sal alone and in combination treatment at the
concentration of 1 and 5 pM. At the concentration of 1 pM, Cro treatment
inhibited LDH release to a greater degree than other chemicals alone. However, at
a concentration of 5 pM, mixture 1 showed the best cytoprotective effect among
these chemicals. In this experiment, low doses (1 and 5 pM) of these anti-oxidants
singly and in combination significantly attenuated toxicity induced by 400 pM
SMX-HA. This suggests that concurrent therapy with low dose anti-oxidants has
the potential to reduce the toxicity of reactive drug metabolites. However, our data
also suggest that these effects occur within a specific range with the potential for
high doses to increase toxicity, suggesting that in vitro the dose must be carefully
controlled to avoid toxicity or enhanced adverse drug effects.
A lipid hydroperoxide assay was used to study SMX-HA induced lipid
peroxidation, an important marker for cellular injury occurring during oxidative
stress. Lipids are a varied group of water insoluble compounds and one of the most
important components of cells. Lipids involve in various functions of cells such as
energy storage molecules, structural components of biological membranes, enzyme
cofactors, as well as intracellular messengers. The properties of lipids make it
become one of the main targets of free radicals like ROS or RNS. All lipids are
derived from fatty acids which can be subdivided into saturated fatty acids,
monounsaturated fatty acids, and polyunsaturated fatty acids (PUFA) based on the
numbers of carbon-carbon double bonds. Saturated fatty acids have no
carbon-carbon double bonds, while monounsaturated fatty acids contain one
double bond. Using the membrane lipids as an example, the major component is
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phospholipids which contain PUFA. PUFA have two or more double bonds which
are susceptible to oxidation (McIntyre and Hazen 2010). Oxidative damage to
lipids (lipid peroxidation) is regarded as an important process which is involved in
various diseases. Their susceptibility to oxidation is mainly due to its structure
which possesses a single methylene group (D C ^D ) group between two adjacent
double bonds (McIntyre and Hazen 2010). ROS are able to abstract a hydrogen
atom from the methylene group, forming a carbon-centered radical that reacts with
molecular oxygen to form the lipid hydroperoxide (Podrez, Abu-Soud et al. 2000).
Generally, the process of lipid peroxidation involves three stages: initiation,
propagation, and termination (Gutierrez, Reboredo et al. 2007). In initiation, ROS
or RNS abstract a hydrogen atom from methylene group of unsaturated lipid and
thus produce a lipid radical; the lipid radical is not stable and easily react with
molecular oxygen to generate lipid peroxyl radicals, once a lipid peroxyl radical is
generated, it will further react with neighbouring lipid radical by abstracting
hydrogen from another lipid molecule, producing lipid hydroperoxides, which is
called propagation. In this process, the resulting radical can then continue a free
radical chain reaction. The propagation stage can be repeated many times and will
be terminated when two radicals react and produce a non-radical species (Catala
2010; Klaunig, Wang et al. 2011). It has been reported that high dose of hydrogen
peroxide can lead to Jurkat cell apoptosis through the membrane lipid peroxidation
(Enukidze, Machavariani et al. 2009). One of the common characteristics of
baicalein, crocetin, resveratrol, and schisanhenol is the ability of capturing free
radicals, and these antioxidants can accelerate termination of lipid peroxidation via
free radical capture and, therefore, protect the cell membrane against oxidation.
This work clearly demonstrated that biologically relevant concentrations of
SMX-HA were associated with the production of significant amounts of oxidative
stress. The concentrations of SMX-HA used were those that would be predicted to
occur in vivo in patients treated with sulphonamides (Rieder et al. 1995). We
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evaluated the anti-oxidant properties of these four chemicals using lipid
peroxidation as a biomarker. It has been demonstrated that at concentration 100
pM and greater, SMX-HA has the ability to bind to the outer surface of neutrophils
and lymphocytes, and thus cause the loss of membrane and show toxicity to
lymphocytes (Naisbitt, Hough et al. 1999). In our project, we measured lipid
hydroperoxide content to evaluate the oxidant effect of SMX-HA on lipids. There
was a significant increase in lipid hydroperoxide content in Jurkar E6.1 cells
treated with 400 pM SMX-HA compared to vehicle treated control cells. Thus, this
suggests that the auto-oxidation of SMX-HA may occur on the plasma membrane,
resulting in the oxidation of lipid, and SMX-HA dose cause oxidative stress on
lipid cell membrane. 5 and 20 pM BE, Cro, Res, Sal, mixture 1, and mixture 2
pretreatment appeared to attenuate lipid hydroperoxide formation mediated by
SMX-HA in a concentration-dependent manner. At the concentration of 5 pM,
pretreatment with Cro for 30 min inhibited lipid hydroperoxide formation to a
greatest degree which decreased lipid hydroperoxide content by 72%. However,
pre-incubation for 30 min with 20 pM of mixture 1 showed the best cytoprotective
effect among these chemicals, with lipid hydroperoxide content induced by
SMX-HA decreased by 96%. We demonstrated that low concentrations (5 or 20
pM) of BE, Cro, Res and Sal attenuate SMX-HA-induced lipid hydroperoxide
formation in concentration-dependent manner. Especially for Cro and mixture 1,
the cytoprotective effect may occur through cytoprotection against lipid
peroxidation.
SMX-HA undergoes auto-oxidation to form SMX-NO, a more reactive
compound than SMX-HA (Rieder et al. 1995). It appears that binding of SMX-HA
and SMX-NO to proteins is a key step in serious ADRs to sulphonamides. Proteins
are essential for biological organisms. They participate in diffferent biological
processes due to various activities and functions. ROS and RNS mediated
oxidative and nitrosative stress may damage proteins and proteins are likely the
most direct target for oxidative damage (Dalle-Donne, Rossi et al. 2003). Proteins
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are composed of amino acids, some of which are susceptible to ROS and RNS and
can form protein carbonyls (Dalle-Donne, Rossi et al. 2003). Protein carbonylation
is an irreversible oxidative modification and usually refers to the formation of
reactive ketones or aldehydes on protein side chains, especially those containing
proline, argnine, lysine, and threonine (Suzuki, Carini et al. 2010). Carbonylated
proteins either undergo proteolysis or accumulation as damaged proteins
(Dalle-Donne, Scaloni et al. 2005). Thus, formation of carbonylated proteins is
regarded as the most commonly modification during protein oxidation. For this
reason protein carbonylation has been widely used in the assessment of cellular
oxidative stress (Luo and Wehr 2009). Briefly, one common method of detecting
protein carbonylation relies upon the reaction between 2,4-dinitrophenylhydrazine
(DNPH) and DNPH detectable protein products like reactive ketone and aldehyde
groups formed during oxidation of proteins (Suzuki, Carini et ah. 2010). These
protein aldehydes and ketones are formed either by oxidation of side chains of
proteins, called primary protein carbonylation; or produced from the radicals
formed during the lipid peroxidation process, called secondary protein
carbonylation. In the primary protein carbonylation, ROS oxidize the side chains
of protein, leading to inactivation, crosslinking, and/or degradation of proteins
(Suzuki, Carini et al. 2010; D'Alessandro, Rinalducci et al. 2011). It has been
reported that 100 pM of hydrogen peroxide leads to the protein carbonyl formation
in a time-dependent manner in Jurkat cells (Cox and Hampton 2007).
We measured the carbonylation of total protein including three subcellular
fractions- the mitochondria, the microsomes, and the cytosol. Microsomal proteins
are a source of CYP (Neuman, Malkiewicz et al. 2000). Proteins within the cytosol
play a key role in signal transduction pathway and glycolysis (Cumming, Andon et
al. 2004). They also act as intracellular receptors and are a key component of
ribosomes (Schwartz 2007). When quantifying protein carbonyl content in Jurkat
£6.1 cells, treatment with 400 pM SMX-HA significantly increases protein
carbonyl content compared to vehicle treated control cells, which suggests that

135

SMX-HA does oxidize protein carbonyls. 5 and 20 pM BE, Cro, Res, Sal, mixture
1, and mixture 2 pretreatment effectively attenuated protein carbonyl formation
mediated by SMX-HA in a concentration-dependent manner. At the concentration
of 5 pM, pre-treatment with mixture 1 for 30 min maximally decreased protein
carbonyl content by 75% (Fig 4B). As same as 5 pM, pre-incubation for 30 min
with 20 pM of mixture 1 also showed the best cytoprotective effect among these
chemicals. Protein carbonyl content was reduced by 82%. As an important marker
of protein oxidation, the measurement of protein carbonylation in our study
indicated that SMX-HA induced oxidative damage. Low concentrations (5 or 20
pM) of mixture 1 attenuated SMX-HA mediated protein oxidation to a great extent,
suggesting that mixture 1 was optimal for attenuation of SMX-HA induced
oxidative stress, especially at the level of the proteins.
Modification of thiol-disulfide bonds of cysteine is regarded as a primary and
important consequence of an altered oxidative states. The importance of this
modulation is involved both in signal transduction in normal cell biology and in
the defence of the proteins against oxidative stress. Redox-related processes can
produce conformational changes to protein structures related to formation of
disulfide bonds, sulfenic, sulfinic, and sulfonic acid. These can lead to the
modification of protein properties and functions. The ionized thiol group is
oxidized to a cysteine radical under high levels of oxidative stress in the cells.
During this oxidation, the formation of sulphenic acids are readily reduced through
reacting with GSH, glutaredoxin, or thioredoxin systems (Baty, Hampton et al.
2005). This reduction is regarded as one of several routes and is depended on the
availability of free GSH which is the most abundant, non-enzymatic antioxidant in
the cells. When this and other natural antioxidant systems are overwhelmed, the
cysteine radicals can react with GSH, forming reversible protein mixed disulphides,
intra- or inter-molecular disulphides bonds, protect the protein from further
oxidation. However, during oxidative stress, the cysteine radical can be further
oxidized to sulphinic and sulphonic acids. These two oxidation products are
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irreversible and dysfunctional modification of proteins. R2D PAGE is a
sophisticated technique that has recently been developed to visualize the cysteine
modulations that undergo molecular changes during different conditions of redox
or oxidative stress (Cumming, Andon et al. 2004). It has been reported that as
many as 400 proteins with oxidized cysteine residues can be detected by R2D
PAGE, these proteins being either in a disulphide state or in oxidized form (Baty,
Hampton et al. 2005). We used this technique to investigate the effects of
oxidative stress produced by SMX-HA treatment and alterations produced by
anti-oxidants pretreatment of Jurkat £6.1 cells. The diagonal line represents all the
proteins that were not altered or modified in the reducing step of the experiment.
The proteins on the diagonal line are either not redox-regulated by reactive
cysteine thiol groups or are irreversibly oxidized proteins that contain reactive
cysteine thiol moieties. Proteins that have formed intramolecular disulfide bonds
before the reduction appear slightly above and to the left of the diagonal line,
while those that formed intermolecular disulphide bonds appear below and to the
right of the diagonal line. Because of the relatively low sensitivity of this technique,
only proteins that are found at high concentration will be visible on the gels, which
may explain why there are so few distinct protein spots found on the gels
(Cumming, Andon et al. 2004). This issue also plays a part in the slight variability
in presence and intensity of protein spots between gels on different runs. In
addition, while one may expect more differences between the SMX-HA treated
cells and DMSO control, both show relatively few protein spots. Although this
could indicate that there are few proteins that formed disulphide bonds, it could
also indicate the oxidation of protein cysteine thiols to irreversible sulphonic acids
(as may be the case in oxidant treated cells). In our studies, there were three
proteins spots that highlighted in 25 kDa region were stood out on some
anti-oxidant control. These spots were identified using mass spectrometry to be
peroxiredoxins (prxs) 1, 2 and 3, respectively. In addition, our laboratory has
identified this protein by mass spectrometry analysis of tryptic fragments in both
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human kidney (HEK 293) and mouse liver (Hepa lclc7) cell lines but not in Jurkat
cells.
Prxs are predominant targets of ROS that enter cells. However, in most of our
studies, only one cluster of 25 kDa protein was seen, that being identified as prx 1
and 2. In addition, the R2D PAGE shown that Prx are located on the right side of
the diagonal line, which represents Prx as having intermolecular disulfide bonded
protein in untreated Jurkat cells. In this case, it has been reported that 2-Cys Prxs
exist as homodimers in a head-to-tail conformation (Smith-Pearson, Kooshki et al.
2008) link by the peroxidatic cysteine residue in conserved NH2-terminal under
physiological conditions. Prxs are known redox-regulated proteins and belong to
the thioredoxin-peroxiredoxin system (Smith-Pearson, Kooshki et al. 2008). Prxs
are encoded by distinct genes and include of six isoforms (Prx 1-6). The 2-Cys
Prxs is the predominant Prxs subfamily, comprising Prx 1-4. Prxs have important
anti-oxidant properties because they detoxify peroxides by transferring reducing
equivalents from NADPH to peroxides (Smith-Pearson, Kooshki et al. 2008), and
reduce hydrogen peroxide to water until their reactive thiol groups are oxidized to
their sulfinic or sulfonic acid forms. Also, the antioxidant properties of Prxs may
be due to the complementary function with glutathione peroxidases and catalases
(Wood, Schroder et al. 2003). All the Prxs contain an active cysteine residue for
catalysis, which can be oxidized by peroxides to reversible cysteine sulfenic acid.
In some cases, Prx-sulfenic acid (-SOH) can be further oxidized by oxidant to
sulfinic (-S02H) or sulfonic (-SO3H) acid, causing the loss of function of Prxs. For
some peroxiredoxins, the sulfinic acid derivatives can be enzymatically reduced
back to functional form by a sulfiredoxin enzyme (Rhee, Chae et al. 2005). As
there are no evident differences in prxs - in anti-oxidants controls as compared to
DMSO control, it was concluded that the anti-oxidant treatments did not produce
oxidative toxicity to these prx proteins. When Jurkat £6.1 cells treated with 400
pM SMX-HA, the disappearance of this protein spot suggested that Prxs
underwent ROS-dependent oxidation to their sulfinic (P-S02H) and sulfonic
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(P-SO3H) acid derivatives. As these oxidation derivatives can not be reduced by
DTT, they would run on the diagonal line with all other proteins that do not occur
as disulphides since they are not altered in the reduction step, thus accounting for
the shift of the Prxs and disappearance of the protein spot from the gel. In addition,
peroxynitrite that generated during the auto-oxidation of SMX-HA also oxidizes
thiols to form nitrite and sulfenic acid. As some of these forms of peroxiredoxins
cannot be reduced by DTT, they would appear on the diagonal line as they do not
have disulfide bonds and with all other proteins that do not occur as disulfides
since they are not altered in the reduction step. When pretreated with 5 pM of BE,
Cro, Res, and Sal, Prx 2 partly reversed and remained in their disulfide bonds form.
This indicated that single anti-oxidant at this concentration all showed a slight
protective effect although they could not completely attenuate SMX-HA mediated
oxidative stress. However, Prx 2 was no longer visible when pretreated with 1 pM
of BE, Res, and Sal. Only pretreatment with 1 pM of Cro slightly reversed the Prx
2. This suggested that these four chemicals possess dose-dependent anti-oxidant
effects and Cro is most suitable to protect against the formation of sulfinic or
sulfonic acid derivatives of Prx 2 induced by 400 pM SMX-HA treatment. When
these anti-oxidants were combined to mixture 1 or mixture 2 and pretreated Jurkat
£6.1 cells with mixture 1 or mixture 2, Prx 2 partly remained in their disulfide
form. As with a single treatment, mixtures also showed concentration-dependent
manner, which represent greater intensity of Prx 2 in 5 pM of mixtures
pre-incubation and lower intensity of Prx 2 in 1 pM of mixtures pre-treatment.
Finally, we compared the anti-oxidant effect of low concentration (1 pM) of single
chemical, mixture 1, and mixture 2. In this case, the mixtures of anti-oxidants
exhibited greater protection than single chemical. In addition, the mixture with Sal
even showed better cytoprotective effect than the mixture without Sal, suggesting
that Sal was a vital contributor to the mixture’s effect. This result supports the
theory that anti-oxidants can work through complementary mechanisms to achieve
a greater protective effect than a single component alone on an equimolar basis,
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permitting lower concentration of each to be used and thereby lowering the
potential for adverse effects. In this experiment, less protein spots and the weak
diagonal line were shown on the gels when we load 85 M-g protein samples. It
might be involved in several factors such as less protein samples or the time of
silver staining. More protein spots were shown up when double protein samples
were loaded on the gels.
In addition, SMX-HA treatment produced more protein spots visible either on
left or on right side of the diagonal line. The increased numbers of proteins can be
explained by oxidation of cysteine residues either into inter-molecular or into
intra-molecular disulphides. Moreover, SMX-HA treatment led to decreased
protein intensity in some cases, which can be explained by overoxidation of thiol
groups. Other factors may be involved in this phenomenon, as an example the
modification of protein produced by SMX-HA may be at a different site (e.g.
phosphorylation); the electrophoretic mobility of proteins would then be changed
in this process (Baty, Hampton et al. 2005).
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CHAPTER 6:

CONCLUSIONS

In conclusion, our results suggest a duality between the pro-oxidant and
anti-oxidant effects of BE, Cro, Res, and Sal. We have also demonstrated that ROS
may be a key biochemical mediator of SMX hypersensitivity. As well, our results
suggest that low concentrations of anti-oxidants therapy may reduce the toxicity of
reactive drug metabolites that generate oxidative and nitrosative stress.
Pretreatment with BE, Cro, Res, and Sal singly and in combination at low
concentration conferred chemoprotection of Jurkat £6.1 cells from SMX-HA
mediated membrane damage, lipid peroxidation, protein carbonylation, and
oxidation of prx 2 protein. In the last case, the mixture of anti-oxidants exhibited
greater anti-oxidant effect than a single anti-oxidant. There were significant
differences between the mixture with and without Sal in these experiments
especially in R2D PAGE, suggesting that Sal was a vital contributor to the
mixture’s effects. The presence of Sal in the mixture enhanced the anti-oxidant
ability of the mixture. Together, the evidence supports the theory that anti-oxidants
can work through complementary mechanisms to have a greater protective effect
than single component alone on an equimolar basis. The potential benefits of
complementary anti-oxidant therapy would include the use of lower concentrations
of each with less chance of toxicity; however, the anti-oxidants used must be
carefully selected in order to enhance drug safety and lower the potential for
negative side effects.
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CHAPTER 7:

FUTURE DIRECTIONS

The present study offered insight on the mechanisms of drug-induced
oxidative and nitrosative stress with special reference to the effect of SMX-HA
auto-oxidization on the redox changes in the cells and the potential for using
complementary anti-oxidant therapy studies using an in vitro model. The use of
BE, Cro, Res, and Sal seem to be ideal traditional Chinese remedies for the
attenuation of oxidative and nitrosative stress by SMX-HA. Work from the present
study should be extended to suitable animal models of oxidative stress, such as
peroxiredoxin knock-out mouse models. An in vivo model will be critical to
determine the reproducibility of the antioxidative effects and the potential effects
of metabolism. The ultimate goal of this research is to use natural origin
anti-oxidants such as BE, Cro, Res, and Sal in patients, in an ideal mixture of
anti-oxidants that can synergistically attenuate oxidative and nitrosative stress via
complementary mechanisms, and thereby prevent oxidative and nitrosative
damage associated with many human diseases as well as reducing the risk of
serious adverse drug effects.
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